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Gonadotropin releasing hormone (GnRH) is the central hormone of reproduction in 
vertebrates. This hormone is secreted from the hypothalamus in response to 
environmental, steroid hormone feedback and other stimuli in a pulsatile manner and 
travels via the hypophyseal portal vasculature to the anterior pituitary.  GnRH binding 
to its receptor on the surface of pituitary gonadotropes stimulates the release of the 
gonadotropin hormones: luteinizing hormone (LH) and follicle stimulating hormone 
(FSH), heterodimers of the common α subunit with the hormone-specific β subunits. 
In addition to secretion of gonadotropin hormones, GnRH stimulates the transcription 
of the gonadotropin subunit genes and that of its own receptor (GnRHR). The GnRHR 
has been shown in recent years to be a constitutive occupant of membrane raft 
microdomains within the plasma membrane. GnRHR association with these 
microdomains appears to be required for the initiation of downstream signaling 
processes within the GnRH signaling network including activation of the mitogen-
activated protein kinase, extracellular signal regulated kinase (ERK). GnRHR-induced 
ERK activation is absolutely required for gonadotropin subunit gene expression and 
fertility in mice.  In this dissertation the components of the GnRHR-associated 
membrane raft microdomain are explored providing insight into how the receptor 
 might be connected to membrane microdomains, the actin cytoskeletal network, and 
the initiation of downstream transcriptional events.  These studies introduce the 
flotillin/reggie proteins and β catenin as novel members of the GnRHR-associated 
membrane raft proteome in addition to identifying a list of proteins for future studies.
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 Chapter 1: Literature Review 
INTRODUCTION 
Gonadotropin releasing hormone (GnRH) is the central hormone of reproduction in vertebrates.  
This hormone is secreted from the hypothalamus in response to environmental, steroid hormone 
feedback and other stimuli in a pulsatile manner and travels via the hypophyseal portal 
vasculature to the anterior pituitary.  A small subset of cells (5-8%) within the anterior pituitary 
expresses the four signature genes associated with gonadotropes: the GnRH receptor (GnRHR), 
the common α glycoprotein subunit (αGSU), the luteinizing hormone β subunit, and the follicle 
stimulating hormone β subunit.  GnRH binding to its receptor on the surface of pituitary 
gonadotropes stimulates a variety of intracellular signaling events culminating in the release of 
the gonadotropin hormones: luteinizing hormone (LH) and follicle stimulating hormone (FSH), 
heterodimers of the common α subunit with the hormone-specific β subunits.  In addition to 
secretion of gonadotropin hormones, GnRH also stimulates the transcription of the gonadotropin 
subunit genes as well as stimulating the transcription of its own receptor.  The GnRHR has been 
shown in recent years to be a constitutive occupant of membrane raft microdomains within the 
plasma membrane. GnRHR association with these microdomains underlies a functional necessity 
for the initiation of some downstream signaling processes within the GnRH signaling network 
including activation of the mitogen-activated protein kinase, extracellular signal regulated kinase 
(ERK). GnRHR-induced ERK activation is absolutely required for gonadotropin subunit gene 
expression and fertility in mice. 
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AN OVERVIEW OF THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS 
Gonadotropin releasing hormone (GnRH) is a decapeptide hormone that is central to successful 
reproductive function in most vertebrate species and all mammals.  Neurons which secrete 
GnRH are initially located within the olfactory epithelium, but early in development these 
neurons migrate to the hypothalamus where they colonize primarily the Preoptic-septal area, and 
to a lesser extent the Mediobasal and Arcuate nucleus areas [1-5].   Meanwhile, the cells that will 
make up the anterior pituitary (adenohypophysis) begin as ectodermal cells in the pharynx from 
which an evagination known as Rathke’s pouch expands to meet an evagination from the 
diencephalon which will become the posterior pituitary (neurohypophysis) [6, 7].   The anterior 
and posterior pituitary lobes will fuse to form the pituitary gland.  Despite being a single gland, 
the two halves are distinct with the anterior pituitary consisting of endocrine cells while the 
posterior pit is composed of neuronal axons to “cell bodies” within distinct hypothalamic nuclei 
of the hypothalamus [8-11].  Unlike the neurohypophysis, the anterior pituitary is derived from 
epithelial cells and does not have a direct axonal connection to the hypothalamus.  Instead a 
unique vascular system carries blood from capillary loops in the median eminence into long 
portal veins, and finally into sinusoids which bathe the anterior pituitary in blood carrying 
hormones secreted by the hypothalamus.  This is known as the hypophyseal portal system and it 
allows the anterior pituitary to experience concentrations of hypothalamic hormones that are 
much higher than those seen by the rest of the body through systemic circulation [12-14].  
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There are five endocrine cell types present in the anterior pituitary including somatotropes, 
corticotropes, lactotropes, thyrotropes and gonadotropes [14].  GnRH is secreted from neurons in 
the hypothalamus in response to physiologic stimuli and is carried by the hypophyseal portal 
circulation to the anterior pituitary.  In the anterior pituitary, GnRH binds to its receptor 
(GnRHR) on the surface of gonadotrope cells where it stimulates, among other things, the release 
of the glycoprotein hormones luteinizing hormone (LH), and follicle stimulating hormone (FSH) 
[15, 16].  Gonadotrope cells of the anterior pituitary respond to varied amplitude and frequency 
of GnRH by secreting FSH and/or LH into systemic circulation where these hormones exert their 
effects primarily upon the gonads [17] (Figure 1).  It appears that GnRH pulse frequency plays a 
role in which of the gonadotropins are secreted with higher frequency pulses of GnRH 
preferentially triggering LH release and lower frequency pulses leading to FSH secretion [18].  
Similarly, increasing pulse frequency of GnRH is correlated with increased LHβ transcription 
and slower frequency GnRH release is associated with increased FSHβ gene transcription [19-
22].   
 
In addition to GnRH, other factors help to regulate the production and release of FSH including 
activins, inhibins, and follistatin.  Activins and inhibins are members of the transforming growth 
factor β (TGFβ) family which exert their influence primarily through autocrine and paracrine 
secretion at all levels of the reproductive axis [23, 24].  Activins are secreted locally and bind to 
their receptor on the surface of gonadotrope cells to help establish and maintain a permissive 
environment for the action of GnRH on FSH production while GnRH itself is capable of 
modulating activin/inhibin mRNA levels [20, 25, 26].  Inhibins on the other hand bind their own 
receptor (betaglycan) and act by antagonizing the actions of activins on FSH synthesis and 
3
Figure1 Overview of the Hypothalamic-Pituitary-Gondadal Axis:  Neurons in the 
hypothalamus secrete GnRH in response to physiologic stimuli.  The GnRH peptide 
is carried by the hypophyseal portal system to the anterior pituitary where it binds to 
its receptor on the surface of gonadotrope cells.  Gonadotrope cells respond to GnRH 
stimulation with pulsatile release of LH and FSH.  Activin and Follistatin are also 
released by cells in the anterior pituitary, providing autocrine and paracrine 
feedback. The gonadotropin hormones (LH and FSH) reach the gonads via systemic 
circulation and stimulate spermatogenesis in the male and follicular development or 
ovulation in the female.  Additionally, the gonads are stimulated to produce the sex 
steroid hormones as well as other factors including inhibin and activin.  These 
hormones can circulate to provide feedback to the hypothalamus and pituitary as 
well as stimulate the development and maintenance of secondary sex characteristics.   
4
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secretion [27-29].  In contrast to activins, endocrine secretion of inhibins from the gonads 
appears to play a more prominent role in its modulation of pituitary gonadotropes, although 
inhibin is produced locally within the anterior pituitary [23, 24, 30, 31].  Meanwhile follistatins 
are activin-binding proteins capable of “bio-neutralizing” activins, masking the binding site for 
its receptor [32-35].  Activins are also capable of inducing the expression of follistatin [36] 
thereby establishing a “self-limiting reciprocal feedback loop” [27].  From the work that has 
been done so far, it is clear that regulation of FSH synthesis and secretion from the anterior 
pituitary is complex, dynamic, and under the influence of a variety of factors.  Interestingly, it 
has recently been shown that activins can also regulate LHβ gene expression under certain 
conditions [37, 38], suggesting that LH production and release may not be as straightforward as 
previously thought. 
 
In females, FSH stimulates follicular growth and maturation early in the follicular phase of the 
menstrual and estrous cycle, while LH stimulates growth during the pre-ovulatory phase, then 
induces ovulation and the formation of a corpus luteum [39-41]. In the male, FSH acts on Sertoli 
cells to stimulate spermatogenesis, while LH acts primarily on Leydig cells regulating the 
production and release of androgens [39, 42, 43].    The gonads also release steroid hormones 
such as estrogen, progesterone or testosterone which provide mostly negative feedback to the 
hypothalamus and pituitary allowing for control of reproductive timing and success [44]. 
 
THE GnRH RECEPTOR 
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In most vertebrates studied at least two, but often three forms of GnRH are present [45-56].  The 
GnRH first identified in the hypothalamus in mammals was termed GnRH I, with a subsequently 
discovered GnRH in chickens being termed GnRH II [45, 57, 58].  Interestingly it is GnRH II 
which has been most conserved from bony fish to humans suggesting that this form of GnRH 
serves an important evolutionary role [59].  A third form of GnRH was discovered in salmon and 
termed GnRH III.  At present this form of GnRH has only been identified in teleost fish [60].  
The existence of three GnRH forms hints that there should be three receptors, one for each form 
of GnRH.  Indeed three types of GnRHRs have been identified, but most were named in order of 
discovery or based on pharmacologic characteristics [59].  Millar and coworkers examined the 
different types of GnRHR discovered in species to date and have suggested a more systematic 
classification into type I, II, or III categories based on phylogenetic relatedness and sequence 
similarity [59].  Under this system, the type I GnRHRs have the highest affinity for GnRH I, 
although they are also capable of binding GnRH II.  Meanwhile the type II GnRHR is highly 
selective for GnRH II and does not bind GnRH I in most cases.  Interestingly, the type II GnRHR 
sequence in humans, chimpanzees, cows and sheep contains a frameshift mutation resulting in an 
internal stop codon and no functional receptor has been identified in these species [59, 61].  
Considering the strong evolutionary conservation of GnRH II, it seems that in these species the 
type I GnRHR must bind and mediate the effects of GnRH II [59, 62].  The type III GnRHR has 
been identified in the bullfrog and several types of teleost fish, but not in mammals [59, 63].   
 
The complementary DNA encoding the mammalian type I GnRHR was first cloned from mouse 
mRNA in 1992 [64, 65]. Analysis of the cDNA revealed the mammalian GnRHR to be a seven 
transmembrane spanning domain G-protein coupled receptor (GPCR) with a very short 
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intracellular carboxyl-terminal domain [65-67].  In other GPCRs, the C-terminal tail is typically 
the site of agonist-induced receptor phosphorylation and β-arrestin binding to target the receptor 
for internalization.  As might be expected the type I GnRHR, which lacks this tail, does not 
rapidly desensitize.  Neither does the type I GnRHR appear to bind β-arrestin or internalize via a 
dynamin-dependent mechanism [68-72].  For this reason the mammalian type-I GnRHR has 
been called a naturally occurring desensitization and internalization resistant mutant [72].  
Interestingly the type II GnRHR, which occurs in mammals as well as other vertebrates, does 
possess a C-terminal tail and is capable of rapid homologous desensitization, binding of β-
arrestin and internalization via a dynamin-dependent mechanism unlike its type I mammalian 
counterpart [70-73].  Indeed, when the C-terminal tail of the catfish type II GnRHR was added to 
the type I rat GnRHR, the chimeric receptor was then shown to rapidly desensitize  pointing to 
the absence of the C-terminal tail as the reason for the type I receptor’s slow desensitization 
kinetics [70].  These findings point to the type I mammalian GnRHR as unique, not only among 
GPCRs, but also within the family of other GnRHRs.  For the purposes of this chapter we will 
focus on the type I mammalian GnRHR expressed in pituitary gonadotropes, referring to it 
simply as GnRHR. 
 
The GnRHR is also distinguished by alterations in several key amino acid residues.  The first of 
these relates to the highly conserved D and N residues located in transmembrane domain (TMD) 
2 and TMD7 of other GPCRs, respectively.  In the GnRHR these residues are effectively 
reversed relative to their orientation in other GPCRs with N replacing D at position 87 in TMD2 
and D replacing N at position 318 within TMD7.  Thus, the GnRHR appears to display a 
naturally occurring reciprocal mutation of these 2 highly conserved residues.  Mutational studies 
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have revealed N87 to be critical for ligand binding and signaling while D318 appears to be 
necessary for coupling to inositol 1,4,5-trisphosphate (IP3) production [74, 75]======.  Another 
unusual feature of the GnRHR is a modified DRY motif at the junction of TMD3 and the second 
intracellular loop.  In most other GPCRs this motif is critical for proper initiation of intracellular 
signaling.  However in the GnRHR, S140 replaces the highly conserved Y residue.  Mutational 
studies to replace S140 with Y demonstrated increased the affinity of ligand binding and 
increased the rate of internalization.  In these studies G-protein coupling did not appear to be 
effected [77].   
 
GnRHR-ASSOCIATED SIGNALING 
The GnRHR, like other GPCRs, changes conformation upon ligand binding which results in 
dissociation of the β and γ subunits from the α subunit of its associated heterotrimeric G-protein.  
In pituitary gonadotropes this most often involves the Gαq/11 subunit [78], although other Gα 
subunits have been implicated in other cell types.  For example, it appears that the GnRHR 
couples to Gαs, Gαq, and Gαi in hypothalamic neurons and to Gαi in prostate cancer cell lines 
[79-81].  In gonadotrope cells the activated, GTP-bound, Gαq/11 then initiates activation of 
phospholipase C (PLC) β, which, in turn, elaborates the second messengers Inositol-1,4,5-
triphosphate (IP3) and diacylglycerol (DAG).  Increases in IP3 triggers rapid release of Ca2+ from 
intracellular stores, while DAG leads to activation of PKC isoforms and subsequently results in 
activation of voltage-gated calcium channels and a more sustained Ca2+ influx from the 
extracellular environment [82-87].  Protein kinase C, Ca2+, and arachidonic acid have been 
shown to participate in GnRH-stimulated release of the gonadotropin hormones from secretory 
vesicles [88, 89].  Additionally activation of PKC and Ca2+ influx from both intra- and 
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extracellular stores have been shown to be required for mitogen-activated protein kinase 
(MAPK) activation in rat pituitary cells in primary culture and mouse gonadotrope-derived αT3-
1 cells [90, 91].   
 
Mitogen-activated protein kinase pathways represent a highly conserved family of kinases which 
participate in intracellular signaling cascades in response to a variety of extracellular stimuli.  In 
the basic model for MAPK activation, a MAP kinase kinase kinase (MAP3K) phosphorylates a 
MAP kinase kinase (MAP2K) which then phosphorylates a MAPK [92].  The GnRHR has been 
shown to activate all four of the classical mammalian MAPK cascades in response to agonist 
binding: extracellular-regulated signal kinase (ERK), stress-activated protein kinase/Jun N-
terminal kinase (SAPK/JNK), p38 MAPK, and big MAPK (BMK/ERK5) [82, 90, 91, 93-96].  
Once activated, MAP kinases phosphorylate a number of substrates within the cell including 
transcription factors, cytoskeletal components, and other enzymes or signaling molecules [97-
100].  A hallmark trait of the MAPK family of enzymes is their ability to translocate to the 
nucleus and activate transcription factors [95, 101].  For example, GnRH stimulation of αT3-1 
cells has been shown to result in phosphorylation and translocation of ERK to the nucleus.  In the 
nucleus ERK then phosphorylates and activates the ternary factor, Elk-1, which binds to serum 
response elements (SREs) within the immediate early gene, Egr-1, promoter and induces 
expression of Egr-1 [102, 103]. 
 
In gonadotrope cells, the mechanisms leading to activation of the MAPKs, ERK and JNK, have 
been extensively studied with somewhat less attention being paid to the p38MAPK and 
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BMK/ERK5 pathways.  Occupancy of the GnRHR by agonist has been shown to lead to ERK 
phosphorylation and activation in gonadotrope cell lines in a mechanism that is dependent upon 
PKC and Ca2+ in addition to other factors [82, 91]. In αT3-1 cells, several PKC isoforms exist; 
among them PKCα, PKCδ, PKCζ, and PKCε have been shown to be activated in response to 
GnRH treatment [104-106].  Interestingly, chronic treatment with phorbol ester has been shown 
to specifically deplete PKCα and PKCε in αT3-1 cells and such depletion reduces GnRH-
induced ERK activation [105, 107, 108].  Among these PKC isoforms, PKCε has also been 
implicated in ERK activation in other cell types by forming a signaling module involving Ras 
and Raf-1 [109] pointing to this as potentially the PKC isozyme involved in GnRH-induced 
activation of ERK.  Classically, PKC has been suggested to directly phosphorylate Raf-1 (c-Raf) 
kinase, which is thought to be upstream of ERK activation by MEK1/2.  Recent studies in our 
lab have paradoxically shown that pharmacologic inhibition or pituitary specific genetic knock-
out of Raf-1 do not inhibit GnRH-induced ERK phosphorylation; however, overexpression of a 
constitutively active Raf-1 construct does result in ERK phosphorylation [110].  These studies 
confirm that Raf-1 may be capable of initiating a cascade which results in ERK phosphorylation, 
but cast doubt as to whether this role is essential or required in the context of pituitary 
gonadotropes.  It is entirely possible that Raf-1 is one of multiple pathways simultaneously 
activated by GnRH treatment which all lead to ERK activation.  
 
Stimulation of gonadotrope cells with GnRH agonists has also been shown to induce a biphasic 
calcium response.  In the first phase, a rapid, initial increase in intracellular Ca2+ is triggered by 
IP3 binding to its receptor on the endoplasmic reticulum resulting in release of Ca2+ from 
intracellular stores.  Later, DAG activates PKC and stimulates a more sustained rise in 
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intracellular Ca2+ concentration via voltage-gated calcium channels [reviewed by [111]]. 
Interestingly, it is this second phase of Ca2+ influx from the extracellular environment which our 
lab has previously shown to be required for GnRH-induced ERK, but not JNK, phosphorylation 
[91].  The mechanism by which extracellular Ca2+ influx is detected by the ERK pathway is just 
beginning to be elucidated.  Previous efforts in our laboratory have shown that GnRH treatment 
of gonadotrope cells results in calcium-loading of the calcium sensing-protein, calmodulin and 
further demonstrated that calmodulin itself was required for ERK activation [102].  More 
recently our laboratory and others have shown that calcium-sensitive proline-rich tyrosine kinase 
(Pyk2) may represent an enzymatic link between calcium influx, calmodulin and ERK activation 
in response to GnRH treatment in gonadotrope cells [112, 113]; however, additional studies will 
be required to fully elucidate this mechanism.  
In contrast to the role of extracellular calcium described above, Ca2+ influx from intracellular 
stores was shown to be important for JNK phosphorylation while ERK phosphorylation 
remained unaffected by the disruption of this calcium pool suggesting that these two MAPK 
pathways might be functionally compartmentalized within the cell [91]. In addition to calcium, 
the JNK pathway in αT3-1 cells has been shown to be mediated by protein tyrosine kinases, such 
as c-src, and the small G-protein, cdc42 [91, 96].  In contrast to the findings of Levi and 
colleagues [96], our group has demonstrated that GnRH-induced JNK phosphorylation is 
independent of DAG-dependent PKC isoforms [91], thus the role of PKC isozymes in GnRH-
induced JNK activation remains controversial.  As c-src is thought to be activated downstream of 
PKC activation, these findings suggest that perhaps c-src is activated by other means, that c-src 
is not essential to JNK activation, or that a phorbol ester-insensitive PKC isoform is involved 
[91].  Our group has also shown that expression of dominant negative MKK7 and dominant 
12
Figure 2 The GnRHR-associated signaling network in gonadotrope cells:  GnRH 
exerts its effect on gonadotrope cells by binding to its receptor, GnRHR.  The 
binding of agonist induces a conformational change resulting in the dissociation of 
the α subunit from the β and γ subunits of the G-protein associated with the receptor.  
The active Gα then stimulates PLC to elaborate the second messengers IP3 and DAG 
which go on to initiate downstream signaling pathways culminating in the initiation 
of MAPK signaling cascades.  Active MAPKs such as ERK and JNK then 
translocate to the nucleus where they activate transcription factors including Elk-1 
initiating transcription of immediate early genes like Egr-1.  Many of these 
immediate early genes are themselves transcription factors which further stimulate 
the transcription of secondary and tertiary genes like the LHβ subunit gene. 
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negative PAK 1 both reduced GnRH agonist-induced JNK phosphorylation confirming that these 
proteins are involved in GnRH signaling to JNK [91] (Figure 2). 
 
GnRH-INDUCED GENE TRANSCRIPTION 
The involvement of MAPKs in gonadotropin subunit gene expression in response to GnRH 
treatment remains controversial.  Many different groups have published apparently contradictory 
results regarding which MAPK members are involved in the activation of transcription factors 
leading to the regulation of GnRH-responsive genes [114], with essentially all of these studies 
carried out in vitro using gonadotrope-derived cell lines.  At least 75 genes have been shown to 
be responsive to GnRH treatment of gonadotrope cells [115].  These genes can generally be 
organized into immediate early genes, secondary genes and tertiary genes.  Immediate early 
genes are characterized by their rapid activation kinetics without the need for new protein 
synthesis indicating that their transcription is triggered by modification/activation of existing 
transcription factors [116, 117].  The immediate early genes primarily function to participate in 
the transcription of secondary and tertiary genes [118].  The levels of many of these immediate 
early genes in unstimulated cells are often undetectable, but they can be rapidly transcribed upon 
stimulation of the cell and resultant PKC activation [119].   
 
The immediate early genes involved in GnRH-mediated transcription include members of the 
activating protein-1 (AP-1) family of transcription factors (c-Jun, c-Fos, ATF-1, -2, -3) as well as 
members of the Ets family of transcription factors such as Elk-1 [120, 121].  Once transcribed, 
the immediate early genes may be activated by one or more MAPK, may form homo- or 
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heterodimers and then bind to their targets on the promoter regions of secondary and tertiary 
genes to initiate transcription.  In general, it appears that JNK is responsible for phosphorylating 
and activating c-Jun and ATF family members which may then go on to activate transcription of 
the LHβ or αGSU glycoprotein subunit gene promoters [122-124].  Similarly, ERK is implicated 
in activation of c-Fos and Elk-1 leading to the transcription of the LHβ and αGSU genes [121, 
122].  However both ERK and JNK have been implicated as activating either c-Fos or c-Jun 
resulting in transcription of the FSHβ gene [94, 125, 126].  Further p38MAPK and ERK, but not 
JNK, have been suggested as upstream activators of Egr-1 which assists in the transcription of 
the LHβ promoter [127].  It seems that the organization of transcriptional modules downstream 
of MAPK cascades might not follow a simple one-to-one association and instead might 
constitute a network of signaling molecules capable of activating interconnected networks of 
transcription factors with differing affinities that regulate themselves on the basis of their 
collective permissive or repressive micro-environments.  For example, both ERK and JNK may 
be capable of phosphorylating and activating Elk-1, but ERK is essential for regulation of Egr-1 
transcription downstream of Elk-1. Meanwhile JNK plays only a minor role in Egr-1 regulation 
possibly setting the baseline tone but not the GnRH-induced response [103].  
 
Interestingly, the MAP kinase phosphatases, MKP-1 and -2 (also known as DUSP 1 and 4), are 
also transcribed as part of the immediate early gene response in gonadotrope cells [128, 129].  
These dual-specificity phosphatases selectively down-regulate MAPK activity by 
dephosphorylating both the Thr and Tyr residues necessary for MAPK activation [130].  So it 
appears that ERK and JNK activation of transcription factors also induces transcription of MKP-
1 and -2 which are capable of dephosphorylating and inactivating ERK and JNK [103, 128].  
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This further demonstrates the complexity of the GnRH-induced gene transcription network by 
adding a mechanism for intracellular negative feedback on MAPK activity through the activation 
of dual-specificity phosphatases.   
 
Deeper into the gene network we find the tertiary genes whose transcriptional response times 
may range from hours to days due in part to the fact that these genes are dependent upon newly 
synthesized transcription factors.  For example, the LHβ subunit promoter requires a 
combination of pre-existing and newly synthesized transcription factors for induction.  In this 
case, the immediate early gene, Egr-1 must first be up-regulated, then Egr-1 and SF-1 must bind 
the LHβ promoter along with other factors before LHβ can be transcribed under the specific 
influence of GnRH [129].  Interestingly Egr-1 was shown to be essential for the production of 
LHβ with the Egr-1 knock-out mouse being infertile and failing to produce the LHβ subunit 
[131, 132].  Similarly work in our lab has generated a pituitary specific conditional double ERK 
knock-out mouse in which ERK was shown to be essential for fertility in female, but not male 
mice, due to deficiencies in LH production [133].  As ERK has previously been shown to be 
crucial for relaying the GnRH stimulus to Egr-1 gene transcription in αT3-1 cells [103], it 
appears that a similar need for ERK exists in vivo. 
 
Adding interesting complexity to this system is the relatively recent finding that β catenin might 
also be involved in mediating the GnRH-induced transcriptional responses.  β Catenin is a 
member of the armadillo gene family of proteins classically known for its ability to bind E-
cadherin and as a signaling molecule in the Wnt/Frizzled pathway [134-136].  In classical 
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Wnt/Frizzled signaling, levels of β catenin in the cytosol are kept low by a destruction complex: 
adenomatous polyposis coli (APC), Axin and glycogen synthase kinase-3β (GSK3β).  In this 
complex, GSK3β phosphorylates and targets β catenin for degradation.  Upon the binding of Wnt 
to its receptor Frizzled on the cell surface, a cascade of intracellular signaling is initiated in 
which GSK3β is phosphorylated on serine 9, which results in its inactivation.  The inactivation 
of GSK3β prevents the phosphorylation and targeting of β catenin for destruction.  Subsequently 
levels of β catenin in the cell increase, leading to its translocation to the nucleus where it acts as a 
transcriptional coactivator [137].  β catenin typically associates with T cell factor 
(TCF)/lymphoid enhancer factors (LEF) to promote the transcription of Wnt target genes 
including many immediate early genes such as c-Jun [138].  
 
Recently, β catenin was found to participate in transcriptional coactivation of the LHβ gene in 
pituitary-derived LβT2 cells in response to GnRH stimulation [139].  In these studies, siRNA 
knock down of β catenin was shown to reduce basal and attenuate GnRH-induced LHβ promoter 
activity.  Further, overexpression of a constitutively active mutant of β catenin along with 
overexpression of Egr-1 and SF-1 were shown to enhance the transcriptional activity of the LHβ 
promoter even in the absence of stimulation by GnRH.  The s concluded that β catenin was 
required for achieving the maximal transcriptional response of the LHβ promoter to stimulation 
by GnRH agonists [139]. In another study, β catenin was shown to be capable of translocating to 
the nucleus in response to GnRH treatment of both LβT2 cells, and HEK293 cells transfected 
with the GnRHR.  Interestingly this same group was able to show that GnRH treatment resulted 
in phosphoinhibition of GSK3β in HEK cells, but they were unable to show this in LβT2 cells 
[140].  Further supporting the role of β catenin is the discovery that LHβ gene expression levels 
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were reduced in embryonic pituitary glands devoid of β catenin [141].  These findings support 
the inclusion of β catenin within the transcriptional network activated in response to GnRH 
treatment in pituitary gonadotrope cells.  
 
GnRHR-MEDIATED SIGNALING AND THE ACTIN CYTOSKELETON 
Recently, it was reported that GnRH agonist treatment is capable of inducing changes in cell 
topography and morphology in pituitary cells and αT3-1 cells.  These changes were evident after 
as little as 1 minute of treatment and after 10 minutes prominent stress fibers, indicative of actin 
remodeling, were detectable [142].  These observations are not without precedent as HEK 293 
cells expressing exogenous GnRHR were also found to show marked changes in cell 
morphology and adhesion in response to GnRH treatment [143].  Additionally several GPCR 
agonists have been shown to promote activation of Rho family GTPases which are known to be 
involved in dynamic reorganization of actin [144].  Under basal conditions, the majority of Rho 
in the cytosol is bound to guanine nucleotide dissociation inhibitors (GDIs) [145] but upon 
stimulation, activated Rho translocates to the membrane to interact with specific targets [144].  
The mechanism of activation of Rho by GPCRs remains unclear, but it is thought to involve 
receptor coupling to Gα 12/13 or Gαq/11.  Dutt demonstrated that overexpression of 
constitutively active mutant Gαq family members was sufficient to induce Rho activation and 
stimulate Rho-dependent cellular responses including actin stress fiber formation [146].  
Activated Rho GTPases are capable of activating WASP/WAVE proteins and diaphanous related 
formins, which are two forms of actin nucleation promoting factors [144, 147].   
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It would seem that cells expressing the GnRHR are not only capable of inducing cytoskeletal 
reorganization they are dependent upon it for the initiation of downstream signaling events.  In 
HEK293 cells stably expressing GnRHR, pre-treatment with cytochalasin D (to depolymerize 
actin) or Latrunculin B (to prevent de novo actin polymerization) prevented GnRH-induced 
phosphorylation of ERK 1/2, c-src, and focal adhesion kinase (FAK).  In these studies a 
dominant negative Rac-1, but not Rho A, was found to prevent GnRH-stimulated 
phosphorylation of FAK leading the authors to conclude that GnRH-induced activation of Rac-1 
was necessary for signaling to ERK via FAK and c-src [143].  Interestingly these authors did not 
find ERK phosphorylation to be downstream of PKC or PLCβ activation.  However in another 
study, stabilization of actin polymerization using Jasplakinolide treatment in αT3-1 cells 
endogenously expressing GnRHR prevented GnRH-induced ERK phosphorylation yet phorbol 
ester treatment was still able to activate ERK [142].   
 
Recent studies in our lab have shown that the actin scaffolding protein, cortactin, was 
phosphorylated in response to GnRH treatment in αT3-1 cells. Curiously, in these experiments, 
knock down of cortactin using siRNA was able to reduce the appearance of lamellipodia and 
membrane ruffles in response to GnRH treatment, yet this did not appear to have any effect on 
ERK phosphorylation.  However, the blunted actin kinetics did result in the loss of secretory 
granule mobilization and a reduction in common glycoprotein α subunit secretion following 
multiple pulses of GnRH [Navratil, Allen, Roberson unpublished manuscript].  Similarly studies 
in LβT2 cells also demonstrated that disruption of the actin cytoskeletal network prevented 
GnRH-induced secretion of LH [142].  Taken together these studies suggest that gonadotropes 
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require an intact and dynamic actin cytoskeleton to coordinate the secretion of the gonadotropin 
hormones and possibly for other intracellular signaling events. 
 
THE GnRHR AND MEMBRANE RAFT MICRODOMAINS 
The plasma membrane makes life possible and allows for a cell to regulate its internal 
environment, yet it must be permeable, adaptable and still maintain biophysical integrity.  In 
spite of its biological importance, we are only beginning to understand how this fundamental 
structure is generated and maintained in a dynamic state.  One of the first steps towards 
elucidating the organization of the plasma membrane came from the “Fluid Mosaic” model 
proposed by Singer and Nicolson.   In this model, the plasma membrane is seen as a fully 
homogenous, two-dimensional, liquid structure in which all membrane proteins and lipids were 
equally distributed and freely-diffuse throughout a uniform plane [148].  As our understanding of 
the plasma membrane evolved, so too did our model for how constituents within the membrane 
were organized.  Studies began to reveal that there were barriers to diffusion even between 
regions of the plasma membrane and that heterogeneities might exist. For example, Spiegel and 
coworkers observed that differences existed in the distribution of endogenous gangliosides 
between the apical and basolateral membranes of rat renal cortex cells [149].  These differences 
were proposed to be maintained by differential sorting or insertion of membrane proteins or by 
tight junctions involved in maintaining polarity in epithelial cells [149, 150]. The “lipid raft” 
hypothesis was first presented in 1992 and was based on the idea that complexes of lipids that 
were poorly solubilized by non-ionic detergents (like Triton X-100) would “float” during sucrose 
gradient fractionation due to low buoyant density and that these potentially represented pre-
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formed complexes present in the cell prior to detergent extraction [151].  The idea that such 
complexes or domains consisting of lipids and proteins could exist and further that these might 
represent functional platforms coordinating cellular processes soon took hold.  These so-called 
membrane rafts were soon defined as small (10-200 nm) dynamic microdomains, enriched in 
cholesterol and sphingolipids [152].  There are several ways membrane rafts are thought to form 
in living cells including as a result of the differential miscibility of lipids which naturally allows 
lipids with highly acylated, tightly packed side chains to preferentially associate with each other 
or with cholesterol, as a result of complex protein-lipid interactions, or as a result of protein-
protein interactions which “trap” lipids in a given region [153-155].  Additionally studies using 
single particle tracking revealed that proteins did not move by random Brownian motion across 
long distances, but did within small domains, infrequently “hopping” between domains [156-
158].  This led to the proposal that actin filaments act as “fences” to trap proteins within small 
regions [156, 157, 159].  The observation that lipids followed similar diffusion restrictions led to 
the extension of this model to include cytoskeletal-anchored transmembrane proteins as 
“pickets” which serve to trap proteins and lipids within such regions [159-161].  Membrane rafts 
are hypothesized to serve an organizational role within the plasma membrane acting as scaffolds 
to compartmentalize or facilitate signal transduction, endocytosis, or to prevent cross-talk 
between the various proteins and lipids that make up the plasma membrane of a cell [152, 162, 
163].   
 
Perhaps because membrane rafts can be easily, albeit crudely, isolated based on density by 
sucrose gradient fractionation in the presence of a non-ionic detergent such as Triton X-100, 
many labs began to isolate and characterize them.  The resulting low density detergent-resistant 
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membranes (DRMs) were often taken to represent the membrane raft compartment.   For this 
reason the membrane raft hypothesis was criticized as being overly simplistic, or as 
superimposing biological significance on a biochemical artifact.  After all, not all things that co-
purify with DRMs represent members of membrane raft microdomains in living cells under 
physiologic conditions [164]. Other early approaches to determine whether membrane raft 
microdomains were of biological relevance included the use of methyl-β-cyclodextrin to extract 
cholesterol from the plasma membrane [165].  This method was predicted to disrupt membrane 
rafts due to their higher composition of cholesterol altering their buoyant density and function 
[165].  Indeed, cholesterol depletion does result in the disassociation of many proteins from 
detergent resistant/low density membrane fractions [166].  Unfortunately removal of cholesterol 
using cyclodextrins can also have a variety of other effects including loss of morphology, 
rounding and loss of viability [166].  In addition to these, methyl-β-cyclodextrin has also been 
shown to remove phospholipids from membranes [167], and may interact with membrane 
proteins [166].  As a result, studies involving cholesterol depletion were often discounted as 
being too harsh, or producing global effects on cellular function and viability that may not be 
related to membrane rafts [166, 168].   
 
EVIDENCE FOR THE EXISTENCE OF MEMBRANE RAFTS 
Experiments in model membranes have shown that different species of lipids do indeed have 
different biophysical affinities for one another.  In model membranes, ternary mixtures of 
sphingomyelin, unsaturated phosphadidylcholine, and cholesterol have been shown to partition 
into cholesterol and sphingolipid rich, liquid ordered (Lo), and cholesterol poor, liquid 
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disordered (Ld), phases over a wide variety of temperatures [169, 170].  Subsequent biophysical 
experiments comparing model membranes to plasma membrane vesicles and to reconstituted 
plasma membrane vesicles along with detergent resistant membrane fractionation from both 
cellular membranes and model membranes have borne out that these Lo domains are likely to 
exist in living cells and that detergent-resistant membrane fractionation is a reliable way to 
isolate them [reviewed by [171]].  Other techniques including transmission electron microscopy 
on plasma membrane sheets has shown that most or all plasma membrane proteins are clustered 
in cholesterol enriched “islands” separated by relatively protein-free spaces.  In these studies, the 
authors noted that some “islands” contained raft marker proteins while others did not, but in 
either case they were all found to be associated with cytoskeletal proteins on the inner leaflet 
[154].  These studies suggest that actin participates in forming, maintaining or stabilizing 
membrane microdomains.  Further support for this hypothesis was found by Chichili and 
Rodgers who determined that actin organizes membrane raft proteins using fluorescence 
resonance energy transfer (FRET) techniques to determine that raft marker proteins were in 
proximity to actin cytoskeletal components [155].  As mentioned previously, single particle 
tracking has revealed that molecules in the membrane do not move as predicted by a “random 
Brownian walk”, but rather move by Brownian motion within finite domains with rare transitions 
between domains [156-158].  Taken together the studies listed here along with others strongly 
suggests that membrane rafts exist in living cells under physiologic conditions. 
 
 
THE GnRHR AND MEMBRANE RAFTS 
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We have previously demonstrated that the GnRHR constitutively and exclusively localizes to 
low density membrane raft microdomains [99, 172, 173]. Accompanying the GnRHR in 
membrane raft compartments are several components of its signaling network including Gαq/11, 
c-Raf kinase, and ERK [172-174].  Considering that these components are all constitutively 
present within the membrane raft compartment it seems reasonable to expect that the GnRHR 
and several members of its signaling network might constitute a pre-formed platform poised and 
ready to rapidly and specifically conduct the GnRH signal as soon as agonist binds the receptor. 
We have also shown ERK activation in response to GnRH to be dependent upon an intact 
membrane raft microdomain [172, 173].  Similar to what was observed for actin perturbation 
[142], activation of ERK could still be achieved with phorbol ester treatment despite the 
perturbation of membrane raft microdomains [173].  It is clear from these studies that something 
is missing in our understanding of how ERK becomes activated in response to GnRH 
stimulation.  Precisely how the GnRH signal is relayed between receptor binding and PKC/ERK 
activation, and why this would require an intact actin cytoskeleton or how membrane raft 
microdomains might be involved remain to be determined.  It appears that some factor (or 
factors) is missing from our current model of GnRH-induced intracellular signaling including 
ERK activation.  We hypothesized that such a factor would be found in association with the 
GnRHR within membrane raft microdomains.  In order to identify a list of candidate proteins 
which might be involved in GnRHR-associated signaling within pituitary gonadotrope cells we 
employed a combination of sub-cellular fractionation and immunoprecipitation to generate 
samples for Mass Spectrometry analysis.  This approach allows us to examine the low density 
membrane raft compartment while taking advantage of more selective antibody-antigen 
interactions to add specificity and relevance to our list of proteins.  In this dissertation, I further 
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go on to use complementary techniques to validate that a selection of the proteins we identified 
represent true participants within the GnRHR-associated membrane raft proteome and potentially 
within the GnRHR-induced transcriptional network. 
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Chapter 2: The Gonadotropin Releasing Hormone Receptor Associates with 
Flotillins/Reggies 1 and 2 within Membrane Raft Microdomains in Gonadotrope Cells. 
 
SUMMARY 
The gonadotropin releasing hormone receptor (GnRHR) is expressed in pituitary gonadotropes 
and is a unique member of the heptahelical G-protein coupled receptor superfamily.  The 
GnRHR has been shown to partition uniquely into membrane raft microdomains in order to 
facilitate productive signaling to a number of signaling pathways including the actin cytoskeleton 
upon stimulation with GnRH.  Here we demonstrate that the flotillin/reggie proteins are found in 
association with the GnRHR in membrane raft microdomains using biochemical, 
immunoprecipitation and imaging approaches in mouse pituitary and clonal αT3-1 cells. GnRH 
administration to αT3-1 cells appears to reorganize the spatial distribution of Flotillins 1 and 2 in 
a manner consistent with actin reorganization. To define the protein composition of the GnRHR-
associated membrane raft microdomain in an unbiased manner, we used immunoprecipitation 
approaches followed by mass spectrometry to identify proteins associated with the raft 
compartment containing the GnRHR and flotillins.  These studies revealed a complex protein 
mixture within the raft compartment potentially representing a number of important signaling 
pathways.   This approach was validated using a group of raft-associated proteins associated with 
the actin cytoskeleton known to be induced by GnRH.  Our studies support the importance of 
protein complexes within the raft that are necessary to productive GnRH signaling within the 
gonadotrope.  
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INTRODUCTION 
 The gonadotropin releasing hormone receptor (GnRHR) is expressed in pituitary gonadotropes 
and is a member of the heptahelical G-protein coupled receptor (GPCR) superfamily [1, 2].  
Within this family, the GnRHR is unique in that it lacks a cytoplasmic carboxyl terminal tail, 
which would otherwise be involved in receptor desensitization and internalization.  For this 
reason, the GnRHR has been called a naturally occurring desensitization resistant mutant [3, 4].  
The GnRHR further distinguishes itself by being an exclusive and constituent resident of 
membrane raft microdomains within the plasma membrane, unlike many other GPCRs which 
only partition into raft domains following activation or receptor dimerization [5].  The GnRHR 
binds to its ligand gonadotropin releasing hormone (GnRH) resulting in dissociation of the 
heterotrimeric G-protein associated with the receptor and initiation of several intracellular 
signaling cascades resulting in calcium influx from both extracellular and intracellular pools, the 
activation of several MAP Kinase pathways including those leading to extracellular signal 
regulated kinase (ERK) 1 and 2 and c-Jun N-terminal kinase (JNK) [6].  Currently the 
mechanisms by which the GnRHR and many members of its signaling network are able to 
partition into the membrane raft compartment, even in the absence of stimulation, are unknown. 
 
Membrane rafts are thought to be small (10-200 nm), dynamic microdomains within the plasma 
membrane that are enriched in cholesterol and sphingolipids [7].  There are several ways 
membrane rafts are thought to form in living cells including as a result of the differential 
miscibility of lipids which naturally allows lipids with highly acylated, tightly packed side chains 
to preferentially associate with each other or with cholesterol, as a result of complex protein-lipid 
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interactions, or as a result of protein-protein interactions which “trap” lipids in a given region of 
the membrane [8-10].  Membrane rafts are hypothesized to serve an organizational role within 
the plasma membrane acting as scaffolds to compartmentalize or facilitate signal transduction, 
endocytosis, or to prevent cross-talk between the various proteins and lipids that make up the 
plasma membrane of a cell [7, 11, 12].  Membrane rafts can be easily, albeit crudely, isolated by 
sucrose gradient fractionation in the presence of a non-ionic detergent such as Triton X-100.  The 
resulting low density detergent-resistant membranes (DRMs) are often taken to represent the 
membrane raft compartment although it should be noted that not all things that co-purify with 
DRMs represent members of membrane raft microdomains in living cells under physiologic 
conditions [13].  We have recently demonstrated a role and requirement for the raft compartment 
and productive signaling through the GnRHR [5, 6, 14]. 
 
Flotillin-1 and flotillin-2 (also known as reggie-2/reggie-1, respectively) are widely expressed, 
highly conserved membrane raft microdomain-associated proteins [15, 16] capable of forming 
stable homo- and hetero-tetramers [17].  Flotillin proteins are constitutively associated with 
membrane raft domains in several cell types [16, 18, 19] and are capable of forming 
preassembled platforms in living cells under physiologic conditions [20] and serve as useful 
markers of membrane raft compartments in some situations.  Although their precise function is 
not yet known, flotillins are thought to participate in membrane receptor-mediated signaling, 
membrane raft-associated endocytosis, phagocytosis and regulation of neurite outgrowth, 
cytoskeletal organization, and scaffolding of molecular processes [21].   
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Recently flotillin-1 was identified through a yeast two-hybrid screen as a binding partner for the 
G-protein subunit, Gαq/11 [22], the same G-protein subunit which participates in GnRHR-
associated signaling in pituitary gonadotropes.  Given that flotillins are thought to participate in 
signaling events and may act as a scaffold for recruitment of proteins into membrane raft 
microdomains, we hypothesized that flotillins interact with the GnRHR or other members of its 
signaling network.  Our group has previously identified other molecules involved in GnRHR 
signaling as inhabitants of the membrane raft compartment including Raf-1 kinase, calmodulin 
and ERK isoforms [5, 14]; however, the full characterization of the raft compartment containing 
the GnRHR has not be fully elucidated.  In order to determine with certainty what other proteins 
may also inhabit the membrane raft compartment linked to the GnRHR, we turned to mass 
spectroscopy (MS) and a proteomic analysis.  Mass spectroscopy is a powerful tool presenting 
the unique opportunity to probe a sample set from an unbiased standpoint allowing for the 
identification of a multitude of targets including those not previously identified.  
 
Here we show that the flotillin proteins are present in membrane raft microdomains in pituitary 
gonadotrope cells along with the GnRHR.  Further we demonstrate that both flotillin-1 and 
flotillin-2 are found in association with the GnRHR within DRMs and that all three co-localize at 
the plasma membrane in gonadotrope-derived αT3-1 cells.  We have used out ability to 
specifically isolate DRM containing the GnRHR to define and begin to validate the GnRHR-
associated membrane proteome in gonadotrope cells. 
 
MATERIAL AND METHODS  
Cells, Antibodies, and Chemicals  
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αT3-1 cells, an immortalized mouse gonadotrope cell line (generously provided by Dr. Pamela 
Mellon, University of California, San Diego), were cultured as described previously [5].  Briefly, 
αT3-1 cells were maintained in high glucose (4.5 g/L) DMEM containing 2 mM glutamine, 100 
U penicillin/ml, 100 µg streptomycin/ml and 1 X nonessential amino acids and 10% FBS. Cells 
were grown in 5% CO2 in air at 37°C in a humidified environment.   Anti-HA antibodies were 
from Cell Signaling Technology (Danvers, MA). Anti-Flotillin-1 and Anti-Flotillin-2 antibodies 
were from BD Biosciences (San Jose, CA).  Anti-LH antibody was a gift from National Institutes 
of Health (National Hormone Peptide Program, A.F. Parlow, Torrance, CA; NIDDK).  The 
GnRHR antibody was raised in a rabbit against 20 amino acids of the second extracellular loop 
(aa193-aa212) of the ovine GnRHR. This sequence shows no overlap with any other receptor or 
peptide.  Pre-immune rabbit serum (NRS) was purchased from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA).  Secondary antibodies and Texas Red-streptavidin used for 
immunohistochemistry were from Jackson Immunoresearch (West Grove, PA).  Buserelin (des-
GLY10 [D-Ser(t-But)6 ]-LH-RH Ethylamide; referred to as GnRHa) and all other chemicals 
were obtained from Sigma. In all experiments, GnRHa was used at 10 nM.  Glass bottom 
microwell dishes for confocal studies were obtained from Mat-Tek (Ashland, MA).  PEI 
(Polyethylenimine) transfection reagent was purchased from Polysciences (Warrington, PA). 
Tissue-Tech OCT compound was from Miles Inc. (Elkhart, IN). 
 
Tissue Preparation and Immunohistochemistry  
All animal studies were completed in accordance with the Cornell University Institutional 
Animal Care and Use Committee. Animals were killed by CO2 asphyxiation and whole 
pituitaries were dissected free and fixed in 4% paraformaldehyde overnight.  Following fixation, 
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pituitaries were embedded in paraffin and sectioned (5 µm).  Pituitary sections were 
deparaffinized in xylene, and rehydrated through ethanol dilution series to distilled H20. Epitopes 
were unmasked by boiling in 10 mM citric acid for 10 min. Slides were blocked and incubated 
with an antibody specific for either flotillin 1 or flotillin 2 for 1 hour at room temperature. Slides 
were then washed with PBS and exposed to an anti-LHβ antibody (1:1250) for 1 hour at room 
temperature. For visualization, slides were incubated for thirty minutes at 37˚ C with Texas Red-
conjugated anti-guinea pig IgG secondary antibodies (1:500) to detect LHβ and Alexa-488 
conjugated mouse IgG to detect either flotillin 1 or flotillin 2. Sections were then washed in PBS, 
stained with DAPI, mounted and imaged using a Zeiss LSM 510 confocal microscope. 
 
Preparation of Cell Lysates and Immunoblotting 
After the indicated treatments, cells were washed twice in cold PBS, and scraped into cold 
radioimmunoprecipitation assay (RIPA) buffer containing 20 mM Tris-HCl (pH 8.0), 137 mM 
NaCl, 10% glycerol, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholate, 
2 mM EDTA, 5 mM sodium vanadate, 0.2 mM phenylmethylsulfonyl fluoride, 5 mM 
benzamidine.  Lysates were cleared by centrifugation and protein concentrations of the lysates 
were determined by Bradford assay. Protein samples were boiled for 5 minutes in SDS load 
buffer, resolved by SDS-PAGE and transferred to polyvinylidene difluoride or nitrocellulose 
membranes by electroblotting. Membranes were blocked with 5% nonfat dry milk (NFDM) or 
1X Casein in TBST (10 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.05% Tween 20) and then 
incubated with primary and horseradish peroxidase (HRP)-conjugated secondary antibodies.  
Protein bands were visualized using enhanced chemiluminescence according to the 
manufacturer’s instructions (PerkinElmer, Boston, MA).  Rather than onto film, 
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chemiluminescence was detected using a BioRad Chemidoc™ XRS+ System and pictures 
analyzed using the Image Lab™ Software from BioRad (Hercules, CA). 
 
 
Cell Fractionations 
Detergent-resistant, low-density membrane fractions were prepared essentially as described 
previously [5]. Briefly, αT3-1 cells were grown to 60-70% confluence in 15 cm2 dishes. 
Following the treatments indicated, cells (~1.5 x 108 per dish) were washed twice in cold PBS, 
and scraped into PBS containing 2 mM sodium vanadate, 0.25 mM phenylmethylsulfonyl 
fluoride, 5 mM benzamidine, and 20mM β-glycerophosphate. Cells were pelleted by 
centrifugation and then resuspended in MES buffer (MBS) containing 25 mM MES, pH6.5, 130 
mM NaCl, and protease inhibitors to a final volume of 400 μL. The samples were adjusted to a 
final concentration of 0.1% Triton X-100 and incubated on ice for 10 minutes. Following dounce 
homogenization (20 strokes), the samples were mixed with an equal volume of 90% sucrose, 
placed in a 5 mL ultracentrifuge tube, and overlaid with a discontinuous gradient of sucrose in 
MBS consisting of 35% (3.7 mL) and 5% (500 μL) layers. The gradients were centrifuged at 
116,000 x g in a SW55Ti rotor for 20 hours at 4˚C. Low-density detergent resistant membranes 
were visible as a band of flocculent material at the 35-5% interface. Fractions (500 μL) were 
collected starting from the top of the gradient.  Total Membrane pellets were prepared as 
described previously by [14]. 
 
Male B6/129 mice (8-20 weeks of age) were euthanized by CO2 asphyxiation. For whole 
pituitary fractionations, pituitaries (n=10) were collected and suspended in 400 μL cold MBS 
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containing 0.1% Triton X-100, homogenized in a glass dounce (20 strokes), and subjected to 
discontinuous sucrose density centrifugation as described above for preparation of detergent-
resistant low-density membranes. Animal use and experimental protocols for these studies were 
approved by the Cornell University Institutional Animal Care and Use Committee. 
 
Silver Staining of Polyacrylamide Gels 
 Samples were prepared as for immunoblotting as described above except that the SDS 
polyacrylamide gels were fixed in 5 gel-volumes of ethanol:glacial acetic acid:water (30:10:60) 
for 12 hours at room temperature, followed by two 30 minute washes in 30% ethanol.  The gel 
was then washed twice for 10 minutes in 10 gel-volumes of deionized water, followed by a 30 
minute incubation in 5 gel-volumes of a 0.1% AgN03 solution (freshly diluted in deionized 
water) at room temperature.  The gel was then rinsed for 20 seconds on each side with a steady 
stream of deionized water.  The stain was developed by adding 5 gel-volumes of an aqueous 
solution of 2.5% sodium carbonate and 0.02% formaldehyde and incubating at room temperature 
until the desired contrast was achieved.  The staining reaction was stopped by washing the gel in 
1% acetic acid for a few minutes followed by rinsing with deionized water. 
Plasmids and Transfections 
The plasmids containing Flotillin-1-GFP and Flotillin-2-GFP constructs were kindly provided by 
Dr. Ben Nichols (Medical Research Council (MRC) Laboratory of Molecular Biology, 
Cambridge, UK).  The plasmid containing the Flotillin-1-Cherry fluorescent construct was 
kindly provided by Dr. Jeremie Rossy (Department of Pathology, University of Bern, Bern, 
Switzerland).  And the plasmid containing the HA-GnRHR construct has been described 
60
previously [23].  All plasmids were transfected into αT3-1 cells using PEI as follows: 500,000 
αT3-1 cells were plated onto 6-well dishes the night before transfection, for each well of a 6-well 
plate, 1µg of plasmid DNA along with 3 µg of PEI reagent were added to 200 µL of serum-free 
media and incubated at room temperature for 15 minutes. The suspension was then added to the 
culture media for a period of 4 hours.  After transfection, the cells were washed and returned to 
growth medium (10%FBS in high glucose DMEM) for 48 hours.  For transient transfections, 
cells were collected following 48 hours of incubation.  For the generation of stable cell lines the 
transfected cells were grown in neomycin selection media containing geneticin (Invitrogen, 
Carlsbad, CA) at 500µg/mL of 10% FBS high glucose DMEM beginning at 48 hours post-
transfection and continuing for a period of at least 3 weeks.  
 
Confocal microscopy  
αT3-1 cells grown on glass bottom microwell dishes were transiently transfected with a  
Flotillin-2 construct with a GFP fluorophore linked to the C-terminus and a Flotillin-1 construct 
with an mCherry fluorophore linked to the C-terminus for 48 hours.  Cells were fixed in 4% 
paraformaldehyde for 10 minutes at room temperature and then imaged. Imaging was done 
utilizing the 63X oil objective and the 488nm and 543nm laser lines of a Zeiss LSM 510 Meta 
confocal microscope. The Cherry and GFP signals were acquired using multi-track mode and no 
crosstalk between Cherry and GFP was observed.  For studies involving the GnRH Receptor a 
construct consisting of a triple HA-tag fused to the N-terminal region of the GnRH Receptor in a 
plasmid containing a neomycin selection cassette was transfected into αT3-1 cells.  Cells were 
grown under neomycin selection conditions (500mg/mL of 10%FBS high glucose DMEM) for a 
period of 3 weeks to ensure stable expression.  This stable cell line was then grown on glass 
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bottom microwell dishes and cells were transiently transfected with either a Flotillin-1 or 
Flotillin-2 construct with a GFP fluorophore linked to the C-terminus for 48 hours.  Cells were 
then fixed in 4% paraformaldehyde for 10 min at room temperature. Cells were blocked in PBS 
containing 3% BSA and then incubated with Rabbit monoclonal anti-HA antibody overnight at 
4°C. The following day, cells were washed and incubated with a Biotin-labeled goat anti-rabbit 
secondary antibody for 1 hour at room temperature.  Finally cells were labeled with Streptavidin-
Texas Red for 1 hour at room temperature.   Phalloidin staining was performed as previously 
described [24].  Cells were then imaged by confocal laser scanning microscopy (CLSM) as 
above.  
 
Immunoprecipitation  
Aliquots (400 μL) of fractions containing suspensions of low-density membranes, or sucrose 
alone, were diluted in an equal volume of PBS and adjusted to 0.01% Triton X-100. Anti-
GnRHR immune serum (IS, 25 μL), anti-Flotillin-1 antibody, anti-Flotillin-2 antibody, or non-
immune rabbit serum (NRS, 25 μL), were added, and the samples were rocked for 1 hour at 4˚C. 
Protein A/G agarose beads (30 μL) were added and the samples were rocked overnight at 4˚C. 
Beads were then washed 3 times in PBS with 0.01% Triton X-100, resuspended in 60 μL of SDS 
load buffer, and boiled.  
 
Samples used for further analysis by Mass Spectrometry were immunoprecipitated using the 
Pierce Crosslink IP kit purchased from Thermo Fisher Scientific (Rockford, IL) rather than using 
the above method.  Anti-GnRHR or anti-flotillin-1 antibodies were crosslinked to protein A/G 
agarose beads according to the manufacturer’s instructions.  Samples were pre-cleared using pre-
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immune rabbit serum and the control agarose resin supplied with the kit.   Pre-cleared samples 
were then incubated with antibody-crosslinked protein A/G beads on a rocker overnight at 4˚C 
followed by immunoprecipitation and sample recovery according to the manufacturer’s 
instructions.  Eluted sample was then boiled in SDS loading buffer and resolved using SDS 
PAGE.  Protein concentration in the eluted sample was measured using the Bradford Assay. 
 
In-gel Digestion and Extraction for NanoLC MS/MS and Mass Spectrometry Data Analysis 
Preparation of SDS-resolved samples for in-gel digestion, extraction and subsequent NanoLC 
followed by tandem MS and data analysis was performed essentially as described previously 
[25] with minor modifications.  Briefly, whole cell detergent resistant membrane raft fractions, 
or immunoprecipitated proteins were resolved by 10% SDS PAGE, then stained using 
SYPRO®ruby (Invitrogen, Carlsbad, CA).  Bands of proteins were then selected and excised 
manually for further processing before being subjected to in-gel digestion with trypsin.   
Mascot version 2.3 was used to identify peptides and proteins using the mouse genome as a 
reference (mouse_refseq_20070725.fasta) and using one decoy database with a 99% confidence 
interval.  All detected peptides were also strictly validated by two criteria: Mascot expectation 
value < 0.01 and Mascot ion score > 36 for whole floating fraction and >25 for the 
Immunoprecipitated samples.  The decoy database search in Mascot search engine allows us to 
estimate false discovery rate for detected tryptic peptides, which yielded 1-3% for each sample 
submitted. After the additional filters described above were applied, the peptide false discovery 
rate decreased significantly down to 0.8%. In each case, all proteins identified in the false 
discovery analysis (in decoy database search) were inferred by a single peptide hit. To be 
included in our lists we required that each protein be represented by 2 or more unique peptides. 
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Pathway Analysis 
Lists of peptides identified in the Mass Spectrometry analyses were subjected to pathway 
analysis using the Ingenuity® Pathway Analysis software package from Ingenuity® Systems 
(Redwood City, CA).  For Ingenuity®, the proteins were identified using their GI accession 
number and the calculated Exponentially Modified Protein Abundance Index (emPAI) number 
was used as a crude estimate of relative abundance within the sample set. 
 
RESULTS 
Flotillins 1 and 2 are present in mouse gonadotrope cells 
To address the question of whether flotillins might be participating in the membrane raft 
microdomain into which the GnRHR partitions in pituitary gonadotrope cells, we initially sought 
to determine whether flotillins-1 and -2 were present in the gonadotrope.  For these experiments, 
whole murine pituitary lysates were obtained and analyzed by Western blot.  The blots were 
probed with mouse monoclonal antibodies directed against flotillin-1 and flotillin-2.  Flotillin-1 
and -2 immunoreactivity were detected in whole murine pituitary lysate (Figure 1A).  As 
gonadotrope cells only represent 5-8% of cells in the anterior pituitary in mice, we next 
examined whether flotillins are expressed specifically in gonadotrope cells or in other pituitary 
cell lineages.  Sections of murine pituitaries were co-labeled with anti-flotillin-1 or anti-flotillin-
2 and anti-LHβ as a marker of gonadotrope cells (Figure 1B). Confocal laser scanning 
microscopy was performed and revealed strong immunoreactivity for flotillin-1 and flotillin-2 
throughout the cells of the anterior pituitary.  As expected, only a small sub-set of these cells 
stained positive for LHβ; however, the merged image reveals flotillin-1 and flotillin-2 co-localize 
with LHβ immunoreactivity in gonadotropes.   
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Figure 1.  Flotillins 1 and 2 are present in mouse gonadotrope cells. 
A. Whole murine pituitary lysates were resolved by SDS-PAGE followed by 
western blot analysis. The blots were probed for flotillin-1 and flotillin-2. B. Fixed 
sections of murine pituitaries were probed simultaneously with anti-flotillin-1 or 
anti-flotillin-2 and anti-LHβ antibodies. Fluorochrome-conjugated secondary 
antibodies (flotillins with FITC; LHβ with Texas Red) were then applied to the 
sections. Confocal laser scanning microscopy imaging was performed to observe 
the sections.  
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Murine Pituitary Tissue 
Murine Pituitary Lysate <- 48 kDa A. 
Flotillin-1 LHβ Merge 
Flotillin-2 LHβ Merge 
B. 
Figure 1 
66
 Flotillins 1 and 2 are present in the detergent-resistant membrane raft compartment in 
mouse gonadotrope cells and αT3-1 cells 
We next examined whether flotillins-1 and -2 were localized constitutively and exclusively to 
membrane raft microdomains in pituitary gonadotrope cells.  For this, detergent-resistant 
membrane fractions were resolved using SDS-PAGE and the blots were probed with anti-
flotillin-1 or anti-flotillin-2 (Figure 2A).  Flotillin-1 and -2 were detected in the low density 
membrane raft fractions, but not in the high density fractions suggesting that the flotillins do 
partition into detergent-resistant membrane raft domains in mouse pituitary cells.  Similar results 
were obtained in αT3-1 cells, an immortalized pituitary gonadotrope cell line, (Figure 2B) and 
support the use of this cell line in subsequent experiments.  To determine whether our sucrose 
gradient fractionations sufficiently reduced the complexity of our samples compared to whole 
cell lysate or the non-detergent-resistant membrane fractions (deep fractions), we resolved 
representative samples from whole cell lysate from αT3-1 cells, total membrane pellet, the low 
density detergent resistant membrane fraction and the deep fraction by SDS PAGE and subjected 
the gel to staining with silver salts (Figure 2C).  These images confirm that there are noticeably 
fewer proteins present in the low density fractions when compared with either whole cell lysate 
or the deep fraction. 
 
Flotillins colocalize within GM1 positive domains at the plasma membrane 
We then asked whether flotillin-1 and flotillin-2 are present within the membrane raft 
microdomain of intact cells.  To address this question we used Alexa 594-conjugated cholera 
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Figure 2.  Flotillins are present in membrane rat fractions. Whole pituitaries (A.) 
and  αT3-1 cells (B.) were lysed and  placed in a discontinuous sucrose gradient. 
Following centrifugation, ten fractions beginning from the top of the gradient were 
obtained. The fractions were then resolved by SDS-PAGE and analyzed by Western 
Blot using anti-flotillin-1 or anti-flotillin-2 antibodies.  (C.)  Silver stained images 
showing the protein present in whole cell lysate, isolated total membrane, low 
density fraction 1, or high density fraction 10. 
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Figure 3.  Flotillins 1 and 2 colocalize within GM1-positive domains at the plasma 
membrane. A. αT3-1 cells that were transiently transfected with flotillin-1-GFP and 
subsequently stained with Alexa 594-conjugated CtxB. The confocal image displays  
flotillin-1 protein in green and ganglioside GM1 in red. Colocalization results in a 
yellow color.  B. αT3-1 cells were transiently transfected with Flotillin 1-cherry, and 
Flotillin 2-GFP.  The transfected cells were then fixed and imaged using laser 
scanning confocal microscopy. 
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toxin B to mark ganglioside GM1-positive membrane raft microdomains in αT3-1 cells 
transiently transfected with a green fluorescent protein (GFP) labeled flotillin-1 (Figure 3A).  
Here the merged image reveals the flotillin-1 fluorescent signal to colocalize within GM1-
positive domains.  Next we questioned whether the two flotillin proteins define the same or 
separate domains by transiently co-transfecting flotillin-1-cherry and flotillin-2-GFP (Figure 
3B).  In this case confocal microscopy revealed that the two flotillins colocalize with each other 
and, by extension, with GM1 within membrane rafts in αT3-1 cells. 
 
Flotillin 1 and 2 redistribute following treatment with GnRH agonist (GnRHa) 
It has previously been shown that αT3-1 cells alter their morphology in response to treatment 
with GnRH agonists [Navratil 2007]; therefore, we reasoned that this might have an effect on 
flotillin distribution and localization at the plasma membrane.  To determine whether this was 
the case, αT3-1 cells were transiently transfected with flotillin-1-GFP and then were either 
untreated or exposed to the pharmacologic GnRH super-agonist (GnRHa), Buserelin, at a 
concentration of 10nM for 15 minutes prior to fixation and imaging (Figure 4 A and B).  
Similarly, αT3-1 cells were either untreated or exposed to GnRHa for 15 minutes before being 
fixed and stained for phalloidin (Figure 4 C and D) as a control showing actin reorganization in 
response to GnRHa treatment.  These images demonstrate that flotillin-1 redistributes within the 
membrane and enriches at lamellapodia and filopodia following GnRHa treatment.  A similar 
pattern was seen with flotillin 2 GFP and redistribution to membrane regions associated with 
filopodial formation (Figure 5).  Interestingly, the images captured also appear to show that 
flotillin 2 forms dynamic aggregates within the plasma membrane.   
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Figure 4. Flotillin-1 redistribution following GnRHa.  A. αT3-1 cells were 
transiently transfected with flotillin-1-GFP and subsequently fixed. The cells were 
then imaged by confocal laser scanning microscopy. In the image, flotillin-1 
appears as a green color. B. The αT3-1 cells  in this image were exposed to 10 nM 
Buserelin for 15 min prior to fixation. The arrows point to the redistribution of 
flotillin-1 around the membrane. C. Untreated αT3-1 cells were fixed and then 
stained with Alexa 594-phalloidin prior to imaging.  Actin appears as a red color in 
the images shown.  D. αT3-1 cells were exposed to 10 nM Buserelin for 15 min 
prior to fixation and then stained as in panel C. 
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Figure 5. Flotillin-2 redistribution following GnRHa. αT3-1 cells were transiently 
transfected with flotillin-2-GFP and live cells were imaged by confocal laser 
scanning microscopy. In the image, flotillin-2 appears as a green color. The cell in 
these images was exposed to 10 nM Buserelin while a live-action video was 
captured.  The above panel shows the cell at rest (untreated), at 3, 5, and 7 minutes 
post exposure to GnRHa. The arrows point to the redistribution of flotillin-2 around 
the membrane near areas of process extention/retraction. 
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Flotillins 1 and 2 coimmunoprecipitate with the GnRH Receptor from membrane raft 
fractions 
Next we tested the hypothesis that the GnRHR and Flotillin occupy the same membrane 
microdomain in pituitary gonadotropes. To test this hypothesis, immunoprecipitation of the 
GnRHR from membrane raft fractions from αT3-1 cells was used.  Both flotillin 1 and flotillin 2 
co-immunoprecipitated with the GnRHR (Figure 6A).  We then performed the reciprocal 
immunoprecipitation using antibodies targeting either flotillin-1 or flotillin-2.  The results 
provide clear evidence that the GnRHR co-immunoprecipitated with both of the flotillins 
independent of GnRH agonist treatment (Figure 6B).  
 
Flotillins-1 and -2 colocalize with the GnRHR 
Understanding that sucrose gradient fractionation might not be an ideal methodology to 
determine whether a functional interaction exists between two proteins in a cell under 
physiologic conditions, we sought to determine whether the flotillin proteins and the GnRHR 
interact at the membrane in intact gonadotrope-derived αT3-1 cells.  A stable cell line expressing 
the murine GnRHR tagged with an HA epitope was transiently transfected with flotillin-1-GFP 
or flotillin-2-GFP.  Image analysis provides important evidence for overlapping expression 
domains for the GnRHR and each flotillin (Figure 7A and B).   
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Figure 6. Immunoprecipitation (IP) of Flotillin 1, Flotillin 2 or GnRHR followed 
by immunobloting: Lipid raft fractions collected from αT3-1 cells that were exposed 
to 0 (untreated) or 10nM Buserelin for 15 min. were incubated with anti-GnRHR  (A), 
anti-Flotillin 2, or anti-Flotillin 1 (B) antibody for 1 hour at 4°C and then to protein 
A/G agarose beads overnight at 4°C. Beads (IPs) were then washed and resuspended in 
SDS loading buffer, boiled, resolved using SDS-PAGE, and then probed by Western 
Blot (IB) as indicated.  
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 Figure 7. Flotillins 1 and 2 colocalize with the GnRHR at the plasma 
membrane.  A.  Cells were stably transfected with HA-GnRHR-BAD then 
transiently transfected with Flotillin 1-GFP or Flotillin 2-GFP, fixed and stained 
with rabbit anti-HA antibody and followed with anti-rabbit Texas Red 
conjugated antibody. Cells were then imaged using laser scanning confocal 
microscopy.  B.  Cells were stably transfected with HA-GnRHR-BAD then 
transiently transfected with Flotillin 1- GFP, fixed and stained with rabbit anti- 
HA antibody followed with anti-rabbit Texas Red conjugated antibody.  Cells 
were then imaged using a z-stack series.  The images represent every 4th image 
from the z stack moving left to right. 
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The membrane raft proteome in αT3-1 cells 
Evidence presented thus far supports the conclusion that the GnRHR and flotillin proteins co-
localize within similar, if not identical, membrane microdomains which led us to hypothesis that 
such microdomains also include other members of the GnRHR signaling network.  In the past, 
we and others have shown Gαq/11, c-Raf kinase, and ERK to be constitutive residents of 
detergent-resistant membrane raft microdomains [5, 14, 26]. Here we sought to further define the 
membrane raft proteome using mass spectrometry.  Sucrose gradient fractionation in the 
presence of Triton X-100 was performed on three independent samples and only the raft fraction 
from each replicate was resolved on a single SDS polyacrylamide gel.  This gel was then 
subjected to silver staining which revealed the raft fractions to be substantially less complex than 
either the deep or whole cell fractions (see Figure 2C).  Further the three independent raft 
fractions all showed remarkably similar staining patterns.  In collaboration with the Cornell Life 
Sciences Core Laboratories, our group decided to attempt a mass spectrometry analysis of one of 
these raft fractions without further resolution via a second gel dimension.  An aliquot of the raft 
fraction was run on a 10% SDS PAGE mini gel and stained with SYPRO®ruby.  Eleven gel 
bands were manually identified (Figure 8) and excised from the gel and then subjected to gel-
based tandem Mass Spectrometry (MS).  The resultant MS data were analyzed by the MASCOT 
2.3 software against the NCBI mouse genome database and revealed 2,032 unique proteins.  This 
list of proteins was then analyzed using the Ingenuity® program which demonstrated a great 
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Figure 8  One Dimensional Gel Images Stained with Sypro®Ruby:  Whole cell 
lysates from αT3-1 cells were subjected to sucrose gradient fractionation.  The 
fraction representing the low density detergent-resistant membrane was then resolved 
by one dimensional SDS PAGE and stained by Sypro®Ruby.  The next lane 
represents the proteins immunoprecipitated out of  the detergent-resistant membrane 
raft fraction resolved by one dimensional SDS PAGE and stained with Sypro®Ruby.   
The entire lanes from each of these gels were divided into bands based on staining 
intensity patterns and these bands were then manually excised and processed for 
Mass Spectrometry.  For reference the molecular weight marker is included and 
labeled with molecular weights in kiloDaltons. 
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variety of proteins predicted to be involved in many, diverse, cellular processes.  These data also 
revealed markers of endoplasmic reticulum and mitochondria suggesting that the complexity of 
these samples was the result of proteins not specifically associated with the plasma membrane. 
As our primary objective was to determine the membrane raft proteome in which the GnRHR 
participates and other proteins that might interact with the GnRHR in that context, we decided 
that our first MS run had not been selective enough.  We therefore decided to move forward 
using immunoprecipitation to isolate what we expected to be relevant proteins out of detergent 
resistant membrane fractions allowing us to better focus on the specific proteins we predicted 
would have a high likelihood of participating in the specific membrane raft microdomain in 
which the GnRHR is resident.  For these experiments, detergent resistant membranes were 
prepared and subjected to immunoprecipitation using antibodies cross-linked to agarose beads to 
prevent contamination of the mass spectrometry sample with the antibodies used to precipitate 
proteins of interest.  In separate experiments, we targeted either the GnRHR or flotillin-1 using 
antibodies directed against each of these proteins.  The resulting samples were then prepared for 
gel-based tandem MS as above with the exception that only 5-7 bands were manually excised 
from each gel (Figure 8).  From these experiments, we identified 243 unique proteins by 
immunoprecipitating the GnRHR and 347 unique proteins by immunoprecipitating flotillin-1.  
We then analyzed the data sets from each of the three mass spectrometry experiments to 
determine which proteins were shared in common between and among the different methods 
(Figure 9A).  This analysis revealed 129 proteins to be present in all three isolations.  We then 
used Ingenuity® to compare the three populations of proteins and to predict the canonical 
pathways represented, a portion of this analysis is shown in Figure 9B. 
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Figure 9.  Summary of mass spectrometry findings.   A. Venn Diagram showing 
proteins identified by mass spectrometry.  Numbers inside the figure represent the 
number of proteins identified by mass spectrometry for each approach with areas of 
overlap indicating shared proteins present in both or all the indicated approaches. B. 
The list of proteins identified via tandem MS all three sample preparation strategies 
was input into the Ingenuity® Pathway Analysis software and a Comparison 
Analysis was run. This figure shows the first 15 canonical pathways in which 
identified proteins from each strategy are predicted to be involved and the relative 
probabilities that the proteins occurring in our analyses were there by chance rather 
than representing a valid pathway (p-value).  In order to more easily visualize the 
differences between p-values among these pathways we took the negative log 
transformation of the p-value in order to maintain the upright orientation of our bar 
graph while maximizing the visual distance between values.  
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Pathway analysis reveals a short-list of proteins involved in several key pathways 
The Ingenuity® analysis of proteins present in all three approaches revealed several canonical 
pathways of interest.  When we compared the proteins involved in each of these pathways, a core 
set of 11 proteins linked to signaling through the actin pathway continued to recur (Table 1).  
We then sought to validate a sub-set of these proteins to determine whether they could be 
identified within the detergent-resistant membrane raft compartment by traditional biochemical 
means.  In these experiments, detergent-resistant fractions were prepared as above and resolved 
by SDS PAGE.  Blots were then probed with antibodies directed against ARP3, actin, cortactin 
or phosphorylated cortactin (Figure 10).  These studies reveal that each of these proteins reside 
constitutively, but not exclusively within detergent-resistant membrane fractions.  Further, all 
three proteins co-localized with the GnRHR and Flotillin 1 in the same raft fraction, thus 
validating our MS studies. 
 
DISCUSSION 
The plasma membrane is arguably the most important part of any living cell.  It separates the 
internal from the external milieu and makes homeostasis possible.  In spite of its central 
importance, there is still much we do not know about how the plasma membrane is organized or 
how this organization impacts cellular behavior in response to hormones.  It is clear that the 
plasma membrane is a heterologous mixture of lipids, proteins, and other molecules, but how are 
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Table 1.   Proteins Identified in 11 of the First 15 Cannonical Ingenuity® 
Pathways Shared by 3 Independent Mass Spectrometry Analyses 
 
Gene 
Accession 
Number 
Protein ID 
[Mus musculus] 
GNB1 GI 6680045 guanine nucleotide-binding protein, 
beta-1 subunit 
ACTR3* GI 23956222 ARP3 actin-related protein 3 homolog 
MYL6 GI 33620739 myosin, light polypeptide 6, alkali, 
smooth muscle and non-muscle 
ARPC5L GI 21312654 actin related protein 2/3 complex, 
subunit 5-like 
MYL12B GI 21728376 myosin light chain, regulatory B 
ACTB* GI 6671509 actin, beta, cytoplasmic  
ARPC4* GI 13386054 actin related protein 2/3 complex, 
subunit 4 
VIM GI 31982755 vimentin 
ARPC3* GI 9790141 actin related protein 2/3 complex, 
subunit 3 
CTTN* GI 75677414 cortactin 
HSPA8 GI 31981690 heat shock protein 8 
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Figure 10.  ARP3, Actin and Cortactin are present in membrane raft fractions.  
αT3-1 cells were either untreated or exposed to 10 nM Buserelin (GnRHa) for 15 min 
prior to lysis and  placement into a discontinuous sucrose gradient. Following 
centrifugation, ten fractions starting from the top of the gradient were obtained. The 
fractions were resolved by SDS-PAGE analysis and analyzed by Western Blot using 
anti-beta Actin, anti-ARP3, anti-Cortactin of anti-phospho (p)- Cortactin antibodies as 
indicated.  Membrane raft fractions blotted for the GnRHR and for Flotillin 1 are 
shown as a control to indicate the raft fractions. 
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these molecules are organized?  The “lipid raft” hypothesis presented a novel, albeit 
controversial, idea that cells may be taking advantage of the properties of different lipids, 
especially cholesterol, to partition the cell membrane into discrete domains which were resistant 
to solubilization with low ionic strength detergents and thus “floated” into low density fractions 
during sucrose gradient centrifugation [7, 27].  This hypothesis has been criticized as a mere 
artifact of placing cell membranes in the presence of detergent and low temperatures, which do 
not occur under physiologic conditions [28].  Recently new techniques including single particle 
tracking, double immunogold electron microscopy, transmission electron microscopy, FRET, 
and Confocal Laser Scanning Microscopy have provided evidence for the existence of membrane 
microdomains in living cells under physiologic conditions [9, 18, 19, 29].  While detergent-
resistant membrane fractionation remains an easy way to isolate components of membrane raft 
microdomains, it is now clear that this technique alone cannot be taken to represent 
physiologically relevant compartments.  For this reason we employed a variety of strategies in 
our current studies linking the raft marker, flotillin specifically to the membrane compartment in 
which the GnRHR localizes. 
 
We have previously demonstrated that the GnRHR partitions into membrane raft compartments 
in gonadotrope cells [5, 6, 14].  Our current studies have shown both flotillin 1 and flotillin 2 to 
be present in cells of multiple lineages within the mouse anterior pituitary, within gonadotrope 
cells, and in a gonadotrope-derived cell line, αT3-1 cells.  In agreement with other cell and tissue 
types [21], we demonstrated that both flotillins partition into detergent-resistant membrane raft 
fractions in mouse gonadotrope cells. We have further shown, in intact cells, that both flotillin 1 
and 2 are found within discrete membrane microdomains in association with both the ganglioside 
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GM1, and the GnRHR.  We also demonstrate that both of the flotillin proteins co-
immunoprecipitate with the GnRHR.  These data suggest that the GnRHR and both flotillin 
proteins exist within the same membrane microdomain in association with each other and imply 
that they may be part of a larger membrane raft-associated complex. 
 
Here we employed mass spectrometry to help us define the membrane raft-associated complex 
our traditional molecular biology data suggested may exist.  We began our proteomic exploration 
with a less-stringent detergent-resistant membrane-based approach to generate a large, 
potentially less-accurate, set of detergent-resistant membrane proteins identified through mass 
spectrometry.  This strategy yielded a large number of proteins which pathway analysis predicted 
to be involved in many, diverse cellular processes providing us with a useful overview of the 
potential targets that could be involved in membrane rafts in gonadotropes.  We then followed 
this study with a more selective immunoprecipitation-based approach and analyzed the proteins 
present in all of our approaches in order to reveal a smaller, more selective, list of proteins which 
we expect to be physiologically relevant in our system.  Ingenuity® pathway analysis comparing 
the proteins present in all three of our MS approaches revealed strong representation of several 
canonical pathways including EIF-2 signaling, oxidative phosphorylation, EIF-4 signaling, and 
regulation of actin-based motility by Rho GTPases. 
 
The identification of the canonical pathway involving regulation of actin-based motility by Rho 
GTPases was of particular interest in our system because it has previously been shown that 
stimulation of gonadotrope cells with GnRH can induce robust actin cytoskeletal reorganization, 
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and that such reorganization is upstream of MAPK activation by not only the GnRHR, but also 
other GPCRs [24, 30, 31].  These studies include the observation that GnRH-dependent 
engagement of the actin cytoskeleton in gonadotropes is clearly linked to secretion of 
gonadotropin subunits, a key component of normal reproduction and fertility (AM Navratil and 
MS Roberson, unpublished data).  Additionally, flotillin 2 has been shown to associate with the 
actin cytoskeleton in several cell types [29].   Here we have shown that flotillin 1 and 2 are 
capable of forming discrete, punctate domains of high fluorescent intensity which rearrange 
themselves and appear to coalesce to filopodia in response to GnRH stimulation.  Others have 
shown that flotillins are capable of forming homo- and hetero-tetramers [17], and exist in visible, 
preassembled platforms[20], consistent with what we observed.  This is suggestive of a role for 
flotillins as a signaling scaffold onto which signaling intermediates may assemble to facilitate 
rapid, efficient, compartmentalized signaling to the actin cytoskeleton in response to agonist 
stimulation.  This role is further supported by our identification of actin, ARP3, cortactin and 
phosphorylated cortactin within raft fractions in αT3-1 cells.   It may indeed be the case that the 
ability for rapid secretory responses with engagement of the GnRHR requires these protein 
complexes within the raft compartment. 
 
The flotillin proteins have also been suggested as defining their own clathrin-independent, 
dynamin-independent endocytic pathway especially in cells that lack caveolin expression [32, 
33].  Additionally, flotillin proteins have been implicated in the formation of membrane raft-
associated signal transduction complexes, including src family kinases, and involving 
inactivation and degradation via endolysosomes [19].  Flotillin-1 was recently shown to be 
required for endocytosis of the dopamine transporter [34].  Given that the GnRHR internalizes 
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and desensitizes in an unconventional manner [4] and that αT3-1 cells lack caveolin [5], it seems 
reasonable to postulate that flotillins may be involved in GnRHR internalization in gonadotrope 
cells.  Our finding that flotillin 1 was capable of responding to GnRHa stimulation by 
redistributing itself coincident with actin cytoskeletal reorganization appears to support this 
conclusion.  
 
We have used a variety of techniques to positively determine that flotillin 1 and 2 and the 
GnRHR are constitutive members of a membrane microdomain which is dynamic, associated 
with GM1 and actin and which is consistent with what have been called membrane raft 
microdomains by others.  These studies support the conclusion that the GnRHR is resident 
within a distinct subpopulation of membrane microdomains defined by the presence of flotillin.  
As the flotillin proteins are more abundantly expressed than the GnRHR, it would seem 
important to point out that it is unlikely that all flotillin-positive domains would contain the 
GnRHR; however it appears that all GnRHR-positive domains do contain flotillins 1 and 2.  
These studies begin to define a membrane compartment/complex(es) that is physiologically and 
functionally relevant to gonadotrope behavior.  Future studies will aim to further define the 
membrane microdomain in which the GnRHR and flotillin are residents and to explore the 
role(s) of flotillin 1 and 2 in the context of pituitary gonadotrope function and the control of 
reproduction. 
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Chapter 3: Beta catenin is a functional participant of the GnRH receptor associated 
membrane raft proteome. 
 
SUMMARY 
The gonadotropin releasing hormone receptor (GnRHR) is a unique member of the G-protein-
coupled receptor superfamily in that it localizes to detergent-resistant membrane rafts within the 
plasma membrane of gonadotropes in an exclusive and constitutive manner independent of 
receptor-ligand interactions.  Using proteomic analyses of specific immunoprecipitated (IP) 
protein complexes from membrane rafts, we previously identified 129 unique peptides within 
this membrane compartment which can be isolated along with GnRHR and flotillin 1.  Pathway 
analysis of these data provides evidence that a number of these peptides are linked to known 
signaling pathways and cellular processes.  Unique among the peptides within the membrane raft 
compartment was β catenin.  β catenin is present constitutively but not exclusively in rafts from 
IP studies linked to the GnRHR and flotillin 1.  In αT3-1 cells, GnRH administration resulted in 
a rapid translocation of β catenin to the nuclear compartment putatively independent of 
phosphorylation of GSK3β, a known modulator of β catenin activity.  We hypothesized that 
β catenin likely regulates key gene transcriptional events linked to activation of the GnRHR in 
gonadotropes.  In order to test this hypothesis, we examined the ability of β catenin to regulate 
the immediate early gene, Nur77; an orphan nuclear receptor known to be regulated by GnRH as 
an immediate early gene in gonadotropes.  Overexpression of β catenin in αT3-1 cells induced 
Nur77 promoter activity is a sequence- and promoter-specific manner.  The combined actions of 
β catenin and GnRH resulted in a synergistic activation of the Nur77 promoter suggesting 
important combinatorial action of GnRH signaling with β catenin.  These studies support the 
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conclusion that membrane raft-localized β catenin may play a critical role in the expression of 
immediate early gene transcription induced by GnRH in gonadotropes. 
 
 
INTRODUCTION 
The gonadotropin releasing hormone receptor (GnRHR) is a unique member of the rhodopsin-
like G-protein coupled receptor (GPCR) family.  Since it was first characterized in 1992 [1, 2], 
the GnRHR has received much attention from the scientific community as a central 
pharmaceutical target for fertility control in mammals.  Despite this level of importance, there is 
still much to learn about the molecular mechanisms regulating and regulated by this receptor.  
The GnRHR lacks an intracellular C-terminal tail which, in other GPCRs, would normally be the 
site of β arrestin-directed internalization [3, 4].  This predicts that the GnRHR is not 
phosphorylated and internalized via the cannonical β arrestin- mediated pathway [5, 6].  The 
GnRHR does desensitize and is internalized, yet the mechanism it uses to accomplish this is still 
unknown.  In addition to its non-canonical desensitization/internalization kinetics, the receptor 
also is a constitutive resident of membrane raft microdomains independent of its activation state 
[7-9]. This differs from many other GPCRs which only partition into membrane raft domains 
following ligand binding or receptor dimerization [10, 11].  Membrane raft microdomains are 
small (10-200 nm), highly dynamic regions of the plasma membrane enriched in sphingolipids 
and cholesterol and are thought to be important compartments for organizing signaling pathways 
induced by receptor occupancy [12].   
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A large body of literature suggests that the GnRHR binds its agonist, gonadotropin releasing 
hormone (GnRH), at the surface of gonadotrope cells and stimulates the dissociation of 
heterotrimeric G-protein subunits. This leads to activation of phospholipase C (PLC), production 
of inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), and stimulation of protein kinase 
C (PKC) in combination with calcium (Ca2+) influx from both intra- and extra-cellular stores, 
and the initiation of several intracellular signaling cascades including the mitogen activated 
protein (MAP) kinase pathways (recently reviewed in detail by [9]).  The GnRHR is dependent 
upon its localization within an intact membrane raft microdomain for its ability to induce some 
of these signaling events. For example, treatment of cells with methyl-β-cyclodextrin prevented 
GnRH agonist-dependent phosphorylation of the MAP kinase, extracellular regulated signal 
kinase (ERK) [7, 9].  Similarly, the GnRHR also requires an unperturbed actin cytoskeletal 
network as pharmacological stabilization of actin polymerization prevented GnRH-induced ERK 
phosphorylation [13].  Interestingly, both of these effects could be by-passed by direct 
stimulation of PKC which did result in efficient induction of ERK phosphorylation [8, 13].  
From these findings it seems clear that our current knowledge of GnRH-induction of 
downstream signaling is incomplete.  We hypothesized that other factors must be involved and 
that these would be found in association with the GnRHR within membrane raft microdomains.  
In a recent study (Chapter 2 of this dissertation), our lab used a combination of detergent-
resistant membrane fractionation and immunoprecipitation of both the GnRHR and a membrane 
raft marker protein, flotillin 1, to generate three sample sets that were subjected to tandem mass 
spectrometry in an effort to define the membrane raft proteome.  We then analyzed the protein 
pathways that were common to all three of these datasets using the Ingenuity® Pathway Analysis 
software to help us identify relevant targets for further study and validation.  Interestingly, β 
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catenin was identified as an interacting protein within the membrane raft using 
immunoprecipitation of both the GnRHR and flotillin 1.  
 
β catenin is a protein known for its ability to bind E-cadherin and as a signaling molecule in the 
Wnt/Frizzled signaling pathway.  In canonical wnt/Frizzled signaling, levels of β catenin in the 
cytosol are kept low by a destruction complex, APC, Axin and GSK3β.  In this complex, GSK3β 
phosphorylates and targets β catenin for ubiquitination and degradation.  Upon the binding of 
Wnt to its receptor Frizzled on the cell surface, a cascade of intracellular signaling is initiated in 
which GSK3β is phosphorylated on serine 9 and inactivated.  The inactivation of GSK3β allows 
levels of β catenin in the cell to increase, leading to its translocation to the nucleus where it acts 
as a transcriptional coactivator on Wnt-responsive genes [14].  Recently, β catenin has been 
shown to participate in transcriptional coactivation of gonadotropin subunit genes in pituitary-
derived LβT2 cells in response to GnRH stimulation [15].  Thus, β catenin may be playing a key 
role in pituitary gonadotrope function; however, relatively little is known regarding how the 
GnRH signaling pathway integrates β catenin activity. 
 
Here we used the Ingenuity® software to identify β catenin as potential member of the GnRHR-
associated membrane raft microdomain.  The present studies confirm that β catenin is present in 
detergent-resistant membrane fractions in the gonadotrope-derived αT3-1 cell line.  We further 
validate that β catenin is capable of co-immunoprecipitating with the GnRHR in membrane rafts. 
Wild type β catenin rapidly translocates to the nucleus following stimulation by GnRH, where it 
is capable of acting as a transcriptional activator on the Nur77 promoter, an immediate early 
gene known to be transactivated in response to GnRH stimulation.  These studies support the 
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conclusion that signaling to β catenin appears to play a role in the integration of immediate early 
gene responses induced by GnRH. 
  
MATERIALS AND METHODS  
Cells, Antibodies, and Chemicals  
αT3-1 cells, an immortalized mouse gonadotrope cell line (generously provided by Dr. Pamela 
Mellon, University of California, San Diego), were cultured as described previously [7].  Briefly, 
αT3-1 cells were maintained in high glucose (4.5 g/L) DMEM containing 2 mM glutamine, 100 
U penicillin/ml, 100 µg streptomycin/ml and 1 X nonessential amino acids and 10% FBS 
(referred to as growth media). Cells were grown in 5% CO2
 
 in air at 37°C in a humidified 
environment.   Anti- β catenin antibody was obtained from Cell Signaling Technology (Danvers, 
MA). Anti-Flotillin 1 and Anti-Flotillin 2 antibodies were from BD Biosciences (San Jose, CA).  
The GnRHR antibody was raised in a rabbit against 20 amino acids of the second extracellular 
loop (aa193-aa212) of the ovine GnRHR, and has been described previously [8].  Nonimmune 
rabbit serum (NRS) was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).  
Horseradish peroxidase conjugated secondary antibodies were purchased from BioRad 
(Hercules, CA).  Buserelin (des-GLY10 [D-Ser(t-But)6 ]-LH-RH Ethylamide; referred to as 
GnRHa) and all other chemicals were obtained from Sigma. In all experiments, GnRHa was used 
at 10 nM.  Glass bottom microwell dishes for confocal studies were obtained from Mat-Tek 
(Ashland, MA).  PEI (Polyethylenimine) transfection reagent was purchased from Polysciences 
(Warrington, PA).  
Pathway Analysis 
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Lists of peptides identified by Mass Spectroscopy were subjected to pathway analysis using the 
Ingenuity® Pathway Analysis software package from Ingenuity® Systems (Redwood City, CA).  
For Ingenuity®, the proteins were identified using their GI accession number and the calculated 
exponentially modified Protein Abundance Index (emPAI) number was used as a crude estimate 
of relative abundance within the sample set. 
 
Cell Fractionations 
Detergent-resistant, low-density membrane fractions were prepared essentially as described 
previously [7]. Briefly, αT3-1 cells were grown to 60-70% confluence in 15 cm2 dishes. 
Following the treatments indicated, cells (~1.5 x 108 per dish) were washed twice in cold PBS, 
and scraped into PBS with protease inhibitors. Cells were pelleted by centrifugation and then 
resuspended in MES buffer (MBS) containing 25 mM MES, pH6.5, 130 mM NaCl, and protease 
inhibitors to a final volume of 400 μL. The samples were adjusted to a final concentration of 
0.1% Triton X-100 and incubated on ice for 10 minutes. Following dounce homogenization (20 
strokes), the samples were mixed with an equal volume of 90% sucrose, placed in a 5 mL 
ultracentrifuge tube, and overlaid with a discontinuous gradient of sucrose in MBS consisting of 
35% (3.7 mL) and 5% (500 μL) layers. The gradients were centrifuged at 116,000 x g in a 
SW55Ti rotor for 20 hours at 4˚C. Low-density detergent resistant membranes were visible as a 
band of flocculent material at the 35-5% interface. Fractions (500 μL) were collected starting 
from the top of the gradient. 
 
 Immunoprecipitation  
106
Immunoprecipitation of proteins was carried out essentially as described by Bliss [8].  Briefly, 
aliquots (400 μL) of fractions containing suspensions of low-density membranes, or sucrose 
alone, were diluted in an equal volume of PBS and adjusted to 0.01% Triton X-100.   Anti-
GnRHR immune serum (IS, 25 μL), anti-Flotillin-1 antibody, anti-Flotillin-2 antibody, or non-
immune rabbit serum (NRS, 25 μL), were added, and the samples were rocked for 1 hour at 4˚ C. 
Protein A/G agarose beads (30 μL) were added and the samples were rocked overnight at 4˚ C. 
Beads were then washed 3 times in PBS with 0.01% Triton X-100, resuspended in 60 μL of SDS 
load buffer, and boiled.  
 
Confocal microscopy  
αT3-1 cells grown on glass bottom microwell dishes were transiently transfected with a plasmid 
containing wild-type mouse beta catenin linked to a GFP fluorophore at the C-terminus for 48 
hours.  Transfected cells were then serum starved for 2 hours followed by treatment with 10nM 
Buserelin for the time indicated, then washed in cold PBS twice. Cells were fixed in 4% 
paraformaldehyde for 10 minutes at room temperature and then imaged. Imaging was done 
utilizing the 63X oil objective and the 488nm laser line of a Zeiss LSM 510 Meta confocal 
microscope.  
Plasmids and Transfections 
The plasmids containing the wild-type mouse β catenin-GFP construct was a generous gift from 
Dr. James Nelson (Stanford University School of Medicine, Stanford, CA) described in [16]. 
Transient transfections into αT3-1 cells were accomplished using PEI as follows: 500,000 αT3-1 
cells were plated onto 6-well dishes the night before transfection, for each well of a 6-well plate 
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1µg of plasmid DNA along with 3 µg of PEI reagent were added to 200 µL of serum-free media 
and incubated at room temperature for 15 minutes, then the suspension was added to the culture 
media over cells for a period of 4 hours.  After transfection the cells were washed and returned to 
growth medium (10%FBS in high glucose DMEM) for 48 hours.  For transient transfections 
cells were collected following 48 hours of incubation.  
 
Luciferase Assays 
The luciferase reporter plasmids used consisted of the mouse promoter regions (described as no. 
of base-pairs upstream of the ATG start site) of either the GnRHR gene or the orphan nuclear 
receptor, Nur77 gene fused upstream of a luciferase reporter. For the Nur77 gene promoter, a 
series of promoter deletion fragments were prepared using PCR and cloned into the luciferase 
reporter construct.  The night before transfection, 500,000 αT3-1 cells were plated onto 6-well 
dishes.  Each well of cells were co-transfected with 1µg of one of the luciferase reporter 
plasmids along with the indicated dose of wild-type  β catenin plasmid DNA, the total amount of 
transfected DNA was held constant by addition of empty pAVT vector.  PEI reagent was added 
to the DNA mixture in a 3:1 ratio of PEI to DNA in 200µL serum free DMEM, the solution was 
then mixed and incubated at room temperature for 15 minutes.  The PEI-DNA suspension was 
then added to cells.  Cells were transfected for a period of 6 hours, the media was changed and 
the cells were allowed to recover in growth medium for 4 hours, followed by treatment with 
10nM Buserelin (GnRHa) in serum free DMEM for 6 hours.   Cells were collected into 250µL of 
Cell Culture Lysis Buffer from Promega (Madison, WI), and then added to Luciferase Assay 
Reagent from Promega (Madison, WI) and relative light units measured on a luminometer 
according to the manufacturer’s instructions. 
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Statistical Analysis  
All data are presented as means +/- SE, with analysis by paired t test (proc: t test) (SAS Institute, 
Cary, NC).  Differences were accepted as significant at p< 0.05. 
 
RESULTS 
Ingenuity® Pathway Analysis of biological functions of peptides identified within the 
membrane raft proteome. 
We have previously used mass spectrometry to describe the GnRHR-associated membrane raft 
proteome using three approaches: isolating the detergent-resistant membrane fraction, 
immunoprecipitation the GnRHR, and immunoprecipitation of the raft marker protein, Flotillin 
1.  Here we used the Ingenuity® Pathway Analysis software to compare the biological function 
networks common to all three of these MS approaches.  The top 9 biological functional networks 
with the highest significance scores are shown in Figure 1.  To more easily visualize the 
differences in significance scores, the negative log of the p-value for each pathway was used 
rather than the p-value.  The asterisk (*) denotes functional networks in which the common 
feature of β catenin as a participant in key pathways.  β catenin was present in five of the top 
nine pathways identified by this analysis. 
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Figure 1. Mass Spectrometry analyses of membrane rafts associated with the 
GnRHR reveal common pathways.  We have previously used mass spectrometry 
to describe the GnRHR-associated membrane raft proteome using three approaches: 
i. isolating the detergent-resistant membrane fraction, ii. immunoprecipitation the 
GnRHR, and iii. immunoprecipitation of the raft marker protein, Flotillin 1.  Here 
we show an Ingenuity® Pathway analysis comparing the functional biological 
networks common to all three of the above MS approaches.  The asterisk (*) 
denotes functional networks in which β catenin is predicted to participate. 
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Figure 2. Ingenuity® Cell-to-Cell Signaling Network. Ingenuity® Pathway 
Analysis identified a Cell-to-Cell Signaling Pathway in which 19 of the 129 proteins 
identified in our three MS analyses appeared.  This figure shows the Ingenuity® 
Network Map.  Grey coloring identifies proteins which appeared in our MS dataset, 
while white coloring identifies proteins which participate in the network, but were 
not identified from our dataset. 
112
Figure 2 
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Table 1: Cell-to-Cell Signaling Network Proteins from 
three MS Analyses 
Abbr. Accession 
Number 
Protein Name Abbr. Accession 
Number 
Protein Name 
CTNNA1 6753294 catenin alpha 1  RPL11 13385408 ribosomal protein L11  
CTNNB1 6671684 catenin, beta  RPL22 6677775 ribosomal protein L22  
EEF1A2 6681273 
eukaryotic translation 
elongation factor 1 alpha 2  RPL23 12584986 ribosomal protein L23  
EEF1D 54287684 
eukaryotic translation 
elongation factor 1 delta 
isoform b  RPL24 18250296 ribosomal protein L24  
G3BP1 6680045 
guanine nucleotide-binding 
protein, beta-1 subunit  RPL27 8567400 ribosomal protein L27  
JUP 28395018 junction plakoglobin  RPL31 16716589 ribosomal protein L31  
MRPL12 22164792 
mitochondrial ribosomal 
protein L12  RPL35 13385044 ribosomal protein L35  
Ncl 84875537 nucleolin  RPL12P2 83745120 ribosomal protein, large P2  
PABPC1 31560656 
poly A binding protein, 
cytoplasmic 1  RPL22L1 13386010 
ribosomal protein L22 like 
1  
RBMX 6755296 
RNA binding motif protein, 
X-linked  
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We next explored the pathways which Ingenuity® Analysis identified from the proteins present 
in each of our three MS analyses.  The three MS approaches outlined above shared 129 proteins 
in common and 19 of these were predicted to participate in a single network identified by 
Ingenuity as involving cell-to-cell signaling (Figure 2).  Proteins shaded grey were present in 
our dataset while those in white are network participants which were not identified by our 
analyses.  Table 1 gives the names, abbreviations and accession numbers of the 19 proteins 
identified within this cell-to-cell signaling network which occur in our list of 129 shared 
proteins.  For the sake of simplicity, proteins which are predicted to participate in this network, 
but which were not identified in our MS dataset were not included in Table 1. 
 
 β Catenin partitions into membrane raft domains in αT3-1 cells.   
We sought to validate the finding of β catenin in our MS studies using biochemical methods.  
We prepared membrane raft fractions from αT3-1 cells as described above, collecting ten 
fractions beginning at the top (low buoyant density) of the gradient.  Fractions were then 
resolved by SDS PAGE and immunoblotted for β catenin and Flotillin 1 as a marker of 
membrane rafts.  As shown in Figure 3, β catenin partitions into the low density membrane raft 
fractions, although its participation in the raft complex is not exclusive as it was also found in the 
high density fraction.  The presence of β catenin within the raft fraction was further validated 
using reciprocal immunoprecipitations using antibodies against the GnRHR and Flotillin 1 
confirm that β catenin is directly associated with GnRHR/Flotillin 1-containing rafts (Figure 4).  
Since the GnRHR changes conformation following the binding of GnRH, cells were exposed to 
10nM Buserelin (GnRHa) to examine the possibility that raft association may be altered 
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Figure 3. β catenin partitions into membrane raft domain in gonadotrope cells.  
αT3-1 cells were lysed and  resolved in a discontinuous sucrose gradient. Ten fractions 
starting from the top of the gradient were obtained following centrifugation. The 
fractions were resolved by SDS-PAGE followed by Western Blot analysis using an 
anti- β catenin antibody. 
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Figure 4. β catenin co-immunoprecipitates with the GnRHR from membrane 
raft fractions.   Lipid raft fractions obtained from αT3-1 cells that were exposed to 0 
(untreated) or 10 nM Buserelin for 15 minutes were incubated with anti-GnRHR or 
anti- β catenin antibody (IP) for 1 hour at 4°C and then exposed to protein A/G 
agarose beads overnight at 4°C. Beads were then resuspended in SDS loading buffer, 
boiled, resolved by SDS-PAGE and probed (IB) as indicated.  
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following GnRHR activation.  Following GnRHa administration, β catenin was present in 
immunoprecipates using the GnRHR and Flotillin 1 antibodies, albeit at varying levels.  Over the 
course of multiple studies, differences in the levels of β catenin in these immunoprecipitation 
experiments were well-within normal experimental variation.  These studies support the 
conclusion that β catenin is present in GnRHR- and Flotillin 1-containing rafts as predicted by 
the mass spectrometry studies.  
 
Wild type β catenin translocates to the nucleus following GnRHa stimulation in αT3-1 cells 
independent of GSK3 β phosphorylation state.  
In other cell types, β catenin has been shown to translocate to the nucleus in response to 
treatment with wnt family members.   We sought to determine whether this might occur in αT3-1 
cells following treatment with the GnRH agonist, Buserelin.  In this experiment, cells were 
transiently transfected with a plasmid containing wild type mouse β catenin linked to a GFP 
fluorophore.  Forty-eight hours later, transfected cells were serum starved for 2 hours, then either 
left untreated or treated with Buserelin for 15 minutes.  Following treatment, cells were fixed and 
imaged using confocal laser scanning microscopy.  Representative images for β catenin-GFP are 
shown in Figure 5A.  These studies suggest that wild type β catenin is distributed diffusely 
throughout the cell in the absence of GnRHa treatment.  Following 15 minutes of GnRHa 
treatment, β catenin translocated to the cell’s nucleus.  For the Wnt pathway, the behavior of β 
catenin is dependent in part upon Wnt-induced phosphorylation of serine 9 on GSK3β.  We 
hypothesized that GnRH-induced modification of GSK3β may help explain the nuclear 
translocation of β catenin in αT3-1 cells.  Interestingly, we find no evidence of GnRH-induced 
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Figure 5. β catenin translocates to the nucleus following GnRHa stimulation 
independent of GSK3β phosphorylation.  A. αT3-1 cells were transiently transfected 
with expression vectors containing wild type β catenin-GFP. Transfected cells were 
treated with either vehicle or Buserelin (GnRHa) for 15 minutes, then fixed and 
imaged using laser scanning confocal microscopy.  Magnification bar is set to 10µm.  
B. αT3-1 cells were cultured in the absence or presence of Buserelin (GnRHa; 10 nM) 
for the times indicated.  Cell lysates were resolved by SDS-PAGE and Western blot 
analysis was used to determine the phosphorylation state of GSK3β and ERKs. 
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changes in GSK3β phosphorylation state (Figure 5B).  In contrast, GnRH induces a robust 
phosphorylation of ERK isoforms suggesting that the GnRH signaling pathway was engaged in 
these experiments.  These studies provide evidence that GnRHa-induced nuclear translocation of 
β catenin occurs independent of serine 9 phosphorylation of GSK3 β.   
 
Identification of promoter sequences within the 5’ flanking sequence of the Nur77 gene that 
are required for β catenin- and GnRH-induced transcriptional activation.   
β catenin is known to act as a transcriptional activator in in gonadotrope cell lines leading to 
transcriptional activation of gonadotropin subunit genes [15].  We hypothesized that GnRH-
induced nuclear translocation of β catenin would lead to transcriptional responses at other gene 
targets in gonadotrope cells.  To test this, we examined a gene promoter known to be activated 
upon stimulation of gonadotrope cells with GnRHa; the orphan nuclear receptor, Nur77 [17].  
Moreover, the Nur77 gene promoter has very recently been demonstrated to be β catenin-
responsive in a colon cancer cell line [18].   Combined, these observations support the possibility 
that the Nur77 gene promoter is an attractive candidate gene to examine further.   Figure 6A 
depicts the organization of AP-1 sites within the Nur77 gene promoter that were identified as 
regulatory elements associated with β catenin action in colon cancer cells.   In our experiment, 
plasmids containing a series of promoter deletions (750, 400, 205 and 95 nucleotides upstream of 
the ATG) of the mouse Nur77 gene cloned upstream of a luciferase reporter were transiently 
transfected into αT3-1 cells.  Either a control plasmid or a β catenin expression plasmid was 
cotransfected with the luciferase reporter.  Following transfection, cells were lysed and luciferase 
activity was determined and standardized to protein levels (Figure 6B).  Overexpression of β 
123
Figure 6.  Identification of promoter sequences within the 5’ flanking sequence 
of the Nur77 gene that are required for β catenin-induced transcriptional 
activation.  A. αT3-1 cells were transiently transfected with luciferase reporter 
plasmids containing nucleotides from -750, -400, -205, or -95 from the transcription 
start site of the mouse Nur77 gene.   Cells were co-transfected with 1 µg of a control 
vector (open bars) or and an expression plasmid encoding wild type β catenin (black 
bar).  Twenty four hours following transfection, cells were lysed and lysates were 
assayed for luciferase activity.  The luciferase data was standardized for protein 
levels and presented as mean + standard error of the mean for fold induction.  B. A 
similar transfection study was carried out as described above except the luciferase 
reporter contained nucleotides from -600 to the transcription start site of the mouse 
GnRH R gene promoter.   
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catenin consistently increased Nur77 luciferase activity when sequences from -750 to -205 were 
present; however, the effects of β catenin overexpression were lost when sequences from -205 to 
-95 were deleted.  The effects of β catenin on promoter activity appear to be specific since 
similar overexpression studies using a 600 nucleotide fragment of the GnRHR gene promoter 
linked to luciferase (also GnRHa responsive) was not affect by β catenin overexpression (Figure 
6C).  These studies support the conclusion that sequences between -205 and -95 of the Nur77 
promoter are required for β catenin action.  This leads to speculation that the AP-1 sites located 
at positions -200 and -180 may play critical roles to facilitate β catenin action on Nur77.      
 
Since we had previously identified Nur77 as an immediate early response gene within the GnRH 
signaling network [17] and found that Nur77 was indeed responsive to β catenin overexpression 
in a sequence-specific manner, we sought to determine if GnRH signaling and β catenin might 
function combinatorially to regulate the Nur77 gene promoter.  To address this, αT3-1 cells were 
transfected with the -750, -205 or -95 Nur77 promoter-luciferase reporters. The -205 and -95 
promoter fragments were selected based on our previous observations that the -205 Nur77 
reporter was clearly the most responsive to β catenin, while the -95 promoter fragment lacked 
this responsiveness.   For each reporter, some cells were co-transfected with the β catenin 
expression plasmid and/or administered Buserelin (GnRHa) in a 2x2 factorial experiment.  
Following transfection and GnRHa treatment, cells were lysed and luciferase activity determined 
and standardized to protein content of the cell lysates.  The preliminary results of these studies 
are reported in Figure 7.  In the context of the -750 Nur77 reporter, GnRH induced a robust ~4 
fold activation consistent with our previous observations [17].  β catenin action was more modest 
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Figure 7. Combined actions of GnRHa and β -catenin on the Nur77 gene 
promoter.   αT3-1 cells were transiently transfected with luciferase reporter 
plasmids containing nucleotides from -750, -205, or -95 from the transcription start 
site of the mouse Nur77 gene.  Some cells received either control solution (open 
bars) or GnRHa (10nM; grey bars) as indicated.   Some cells were co-transfected 
with 1 µg of a control vector (open bars) or and an expression plasmid encoding wild 
type β catenin (black bar) or the combination of β -catenin and GnRHa (black/grey 
bars).  Twenty four hours following transfection, cells were lysed and lysates were 
assayed for luciferase activity.  The luciferase data was standardized for protein 
levels and presented as mean + standard error of the mean for fold induction.  
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(~2 fold); however, the combined actions of GnRHa and β catenin resulted in a synergistic 
transcriptional response.  A similar trend was evident using the -205 Nur77 reporter; however, 
GnRH action was less robust (~70% increase) and the response to β catenin was more robust as 
observed in earlier studies.  When β catenin action was lost with the deletion of the Nur77 
promoter from -205 to -95, the synergistic response was lost.  These preliminary studies suggest 
that signaling activities induced by GnRH interact with β catenin to promote Nur77 gene 
transcription in a synergistic manner.  Additional studies in this area are necessary to fully 
elucidate the molecular mechanisms associated with these compelling observations.   
 
DISCUSSION 
β catenin emerged from our data sets as a likely candidate for further study in part because it was 
represented in all of our different approaches to determine the cohort of peptides that populate 
the raft compartment, and because it has been implicated in signaling processes involving the 
GnRHR and its associated signaling networks [ [15, 19, 20].  β catenin is a ubiquitously 
expressed protein originally identified, along with α and γ (junctional plakoglobulin) catenin, in 
complex with the calcium-dependent transmembrane glycoproteins, cadherins [21, 22].  
Although β catenin is capable of binding to cadherins at the cell membrane, studies in Madin-
Darby Canine Kidney cells have demonstrated that perhaps 50% of catenins within a cell are not 
associated with cadherins [23].  Further, Stewart and coworkers identified four distinct pools of 
catenins of which only one includes association with cadherins [24].  These findings suggest that 
the roles for β catenin within cells are likely many and complex.  Consistent with this, β catenin 
is also known to participate in Wnt/Frizzled signaling where it acts as a transcriptional activator 
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of Wnt-responsive genes [14].  Recently, β catenin has been shown to participate in a variety of 
GPCR-mediated signaling pathways, including those of the GnRHR [20].   
In the present studies, we have shown that β catenin is not only capable of participating in 
downstream signaling processes, but that it also associates with the GnRHR either directly or as 
part of a larger complex of proteins within membrane rafts.  Interestingly, GnRH treatment has 
been shown to induce changes in cell morphology and rearrangement of the actin cytoskeleton 
[13, 25, 26].   In light of this information, our finding that β catenin is found in association with 
the GnRHR within the membrane raft compartment may be suggestive of a mechanistic 
connection(s) between GnRHR occupancy and changes in the actin cytoskeletal network.  This 
notion is substantiated from data described within Chapter 2 of this dissertation.  β catenin 
appears to be a likely candidate for communication to the actin cytoskeleton since it is known to 
bind to at least two proteins which are also capable of binding actin: α catenin and adenomatous 
polyposis coli (APC).  Additionally, our analysis of proteins identified by MS that were 
immunoprecipitated with the GnRHR included a subset of proteins predicted to be involved in 
the “Regulation of Actin-based motility by Rho” canonical pathway which may also point 
toward mechanistic means by which the GnRH signal is “perceived” by the cytoskeleton.  
Finally, the cell-to-cell signaling network in which we identified β catenin includes integrins, 
Rap (a small GTPase), and MAPK family members.  This further suggests that β catenin may be 
participating in a network which is capable of relaying the GnRH signal to the actin cytoskeletal 
network resulting in the activation of MAPK family members possibly including ERK.  
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β catenin is capable of responding to GnRH treatment by translocating to the nucleus in 
gonadotrope-derived αT3-1 cells, consistent with the finding of Gardner et. al. in LβT2 cells, a 
related cell line [27].  Once in the nucleus, β catenin appears to act as a transcriptional activator 
in αT3-1 cells regulating the expression the orphan nuclear receptor, Nur77.  This is consistent 
with the findings of Salisbury and colleagues who have shown that β catenin is capable of 
binding to SF-1and acting as a co-activator in association with Egr-1 to promote maximal 
expression of the LHβ subunit gene promoter in HEK293 and LβT2 cells [15].  Importantly, we 
show that the effects of β catenin were relatively specific since β catenin overexpression was not 
sufficient to regulate the GnRHR gene promoter, another GnRH-responsive gene in aT3-1 cells 
[28-30].  These studies have also identified the region from -205 to -95bp from the ATG of the 
Nur77 gene as important for β catenin-dependent transcriptional aactivation.  Inclusion of the 
more distal segment from -750 to -205 appears to reduce β catenin’s ability to induce 
transcription of the luciferase reporter element relative to the profound increase seen when 
sequences distal to -205bp are removed.  This suggests that a repressive element may be present 
distal to 205 bp upstream of ATG which then requires the binding of another factor for maximal 
promoter activity.  Curiously, loss of this distal segment also blunts the synergistic effect seen 
with both overexpression of β catenin and GnRH stimulation.  This suggests that a GnRH-
response element (GnRH-RE) or other hormone-responsive enhancer element might be present 
within the distal segment of the promoter to mediate a putative synergistic effect.  Since 
overexpression of β catenin alone was sufficient to induce activation of these promoter elements 
in our studies, it seems that endogenous levels of β catenin may be limiting in the absence of 
hormone treatment.  However, transcriptional activity of these promoter fragments could be 
regulated even higher once cells were stimulated with GnRH suggests that GnRH-induced 
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signaling events may augment β catenin-induced transcriptional activity.  In particular, the 
activation of MAP kinases and resultant activation of the transcription factors they regulate are 
likely to be important in determining the maximal activity of this promoter.  Interestingly, 
Salisbury also discovered that β catenin is capable of interacting with TCF/LEF family members 
in response to GnRH to regulate expression of the transcription factor, cJun [19], while another 
group identified cJun itself as an interacting partner of β catenin, augmenting transactivation of 
the Nur77 promoter in SW480 cells [18].  These findings support our conclusion that β catenin 
overexpression is sufficient to activate the Nur77 promoter, but that response to GnRH treatment 
likely requires the participation of activated transcription factors possibly including cMyc, cJun, 
cFos or other factors previously shown to participate in the transactivation of immediate early 
genes in response to GnRH treatment.   
 
 In our studies, we were unable to show phosphorylation of GSK3β, the canonical negative 
regulator of β catenin in Wnt signaling, on serine 9.  In Wnt/Frizzled signaling, phospho-
inactivation of GSK3β is prerequisite for rescue of β catenin from the destruction complex and 
subsequent translocation to the nucleus where β catenin activates the transcription of Wnt-
responsive genes.  That we were unable to see enhanced phosphorylation of Ser 9 on GSK3β 
does not necessarily provide supporting evidence that this kinase is not involved in our system.  
Diverse mechanisms for regulation of GSK3β exist within cells and phosphorylation of Ser 9 
represents a single potential mechanism.  GSK3β is capable of associating with other proteins in 
a complex which then augments its kinase activity.  For example, GSK3β catalytic activity is 
enhanced when it is associated with APC and Axin in the so-called destruction complex [31-33].  
Meanwhile GSK3β association with one of the GSK3β-binding proteins, Frat 1 or Frat 2 results 
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in inhibition of its catalytic activity [33-35].  Further, GSK3β has recently been shown to be 
directly phosphorylated by ERKs in hepatocellular carcinoma cells on its threonine 43 residue 
[36] indicating that there may be multiple phosphorylation sites capable of activating and 
inactivating GSK3β and those at play may vary with cell type and signaling pathway. 
 
Finally, we have demonstrated that β catenin is constitutively but not exclusively localized to 
detergent resistant membrane raft microdomains along with the GnRHR.  We propose that 
membrane raft domains may play a role in β catenin activation in response to GnRH stimulation.  
In a manner similar to that proposed for ERK activation [Bliss 2007], we speculate that 
membrane rafts serve as a platform for the association of β catenin with key signaling 
intermediates.  As we have previously demonstrated that kinases including c-Raf and ERK [7-9] 
are present within membrane raft microdomains, it seems reasonable to predict that β catenin 
phosphorylation could be facilitated within this membrane compartment where receptor and 
signaling intermediates are predicted by be in close proximity.  It is possible that membrane raft-
associated β catenin might become phosphorylated on a number of residues triggering its 
activation and nuclear translocation.  For example, phosphorylation of β catenin on Thr 393 has 
previously been shown to promote β catenin stability and transcriptional activity [37].  Similarly 
phosphorylation on Tyr residues (Y86, Y654, and Y670) is associated with β catenin 
translocation to the nucleus and nuclear stabilization [38, 39].  Thus, it seems reasonable to 
postulate that β catenin cycles through the membrane raft compartment as a necessary step to 
becoming activated and translocating to the nucleus, similar to what occurs GnRH-induced ERK 
activation [8, 9, 40].  There is also the intriguing possibility that β catenin activation might be 
associated with its dissociation from proteins such as α catenin or APC that then mediate effects 
133
on the actin cytoskeleton linking GnRH stimulation to changes in cell morphology.  While such 
speculation is exciting, it is clear that more work needs to be done in this area to sort out the 
relationship between β catenin, the GnRHR, membrane raft microdomains, and downstream 
signaling events. 
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Chapter 4: Conclusions and Future Directions 
 
INTRODUCTION 
Gonadotropin releasing hormone (GnRH) is the central hormone of reproduction in vertebrates.  
Neurons in the hypothalamus integrate environmental cues, steroid hormone feedback, and other 
stimuli into the pulsatile secretion of GnRH into the median eminence [1-4].  The hypophyseal 
portal vasculature then delivers GnRH to the anterior pituitary where it binds to its receptor on 
the surface of gonadotrope cells.  The agonist-bound GnRH Receptor (GnRHR) stimulates a 
variety of intracellular signaling events culminating in the differential release of the 
gonadotropin hormones: luteinizing hormone (LH) and follicle stimulating hormone (FSH) [5, 
6]. The gonadotropin hormones are glycoprotein heterodimers composed of the common α 
subunit with the hormone-specific β subunits.  In addition to secretion of gonadotropin 
hormones, GnRH also stimulates the transcription of the gonadotropin subunit genes as well as 
stimulating the transcription of its own receptor [7-11].  The activation of mitogen-activated 
protein kinase (MAPK) cascades is an essential component of hormone-induced transcription of 
target genes.  
The GnRHR has been shown in recent years to be a constitutive occupant of membrane raft 
microdomains within the plasma membrane [12-14]. Membrane raft microdomains are defined 
as small (10-200 nm), dynamic microdomains within the plasma membrane that are enriched in 
cholesterol and sphingolipids [15]. Additionally, a number of studies have suggested actin to be 
intimately involved in the organization or maintenance of membrane raft microdomains in cells. 
Interestingly, the ability of the GnRHR to initiate some downstream signaling processes 
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including activation of the MAPK, extracellular signal regulated kinase (ERK) has been shown 
to require an unperturbed membrane raft microdomain as well as a dynamic and responsive actin 
cytoskeleton [12-14].  GnRHR-induced ERK activation is absolutely required for gonadotropin 
subunit gene expression and optimal fertility in mice [16].  Therefore elucidating the means by 
which the GnRHR is able to partition into membrane raft microdomains and productively couple 
to ERK activation is essential to our understanding of fertility. 
THE GnRHR AND FLOTILLINS 
Flotillin-1 and flotillin-2 (also known as reggie-2/reggie-1, respectively) are widely expressed, 
highly conserved membrane raft microdomain-associated proteins [17, 18] capable of forming 
stable homo- and hetero-tetramers [19].  Flotillin proteins are constitutively associated with 
membrane raft domains in several cell types [18, 20, 21], are capable of forming preassembled 
platforms in living cells under physiologic conditions [22], and serve as useful markers of 
membrane raft compartments in some situations.  Although their precise function is not yet 
known, flotillins are thought to participate in membrane receptor-mediated signaling, membrane 
raft-associated endocytosis, phagocytosis and regulation of neurite outgrowth, cytoskeletal 
organization, and scaffolding of molecular processes [23].  Recent identification of flotillin-1 as 
a binding partner for the G-protein subunit, Gαq/11 [24], the same G-protein subunit which 
participates in GnRHR-associated signaling in pituitary gonadotropes, led us to hypothesize that 
flotillins interact with the GnRHR or other members of its’ signaling network.   
In this dissertation we demonstrate that the flotillin/reggie proteins are found in association with 
the GnRHR in membrane raft microdomains using biochemical, immunoprecipitation and 
imaging approaches in mouse pituitary and clonal αT3-1 cells. GnRH administration to αT3-1 
cells appears to reorganize the spatial distribution of flotillins 1 and 2 in a manner consistent with 
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actin reorganization.  At this point the mechanistic relevance for flotillin association with the 
GnRHR is unclear.  Future studies are needed to determine whether flotillins are required for 
GnRHR participation in the membrane raft compartment or for coupling to downstream 
signaling events.  Experimental approaches utilizing siRNA silencing or knock down of each of 
the flotillins followed by assays to determine whether the GnRHR is still capable of partitioning 
into membrane rafts and activating downstream signaling targets such as ERK will be 
instrumental to defining the requirement for flotillins.  Generation of a dominant negative 
flotillin may also provide an important tool for the study of flotillin’s involvement in the 
organization of a GnRHR-associated membrane raft compartment.  Another intriguing 
possibility is that the flotillins take the place of caveolins in cells, such as the αT3-1 cell line, 
which lack caveolae.  To determine whether this may be the case future studies may include 
establishing a clonal line of αT3-1 cells in which flotillin expression has been silenced. In such 
cells exogenous caveolin can then be expressed in order to determine whether caveolae can take 
the place of flotillin-associated membrane microdomains and whether GnRHR-mediated 
signaling still progresses in a similar fashion.   
 
THE GnRHR-ASSOCIATED MEMBRANE RAFT PROTEOME 
 
We have previously demonstrated that the GnRHR constitutively and exclusively localizes to 
low density membrane raft microdomains [12-14]. Accompanying the GnRHR in membrane raft 
compartments are several components of its signaling network including Gαq/11, c-Raf kinase, 
and ERK [12, 13, 25].   As mentioned above, ERK activation in response to GnRH to be 
dependent upon an intact membrane raft microdomain and productive engagement of the actin 
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cytoskeleton [13, 14, 26].  Curiously activation of ERK could still be achieved with phorbol ester 
treatment despite the perturbation of either membrane raft microdomains or stabilization of actin 
polymerization [12, 13, 26].  These studies revealed that our understanding of how the GnRH 
signal is relayed between receptor binding and PKC/ERK activation is incomplete.  It appears 
that some factor (or factors) is missing from our current model of GnRH-induced intracellular 
signaling including ERK activation.  We hypothesized that such a factor would be found in 
association with the GnRHR within membrane raft microdomains.  In order to identify a list of 
candidate proteins we employed a combination of sub-cellular fractionation and 
immunoprecipitation to generate samples for Mass Spectrometry analysis.  This approach 
allowed us to examine the low density membrane raft compartment while taking advantage of 
more selective antibody-antigen interactions to add specificity and relevance to our list of 
proteins.   
Mass spectroscopy (MS) is a powerful tool, when applied to biology it allows for the systematic 
and unbiased identification of a multitude of targets including those not previously considered.  
The test is exquisitely sensitive, but the results might not be very specific.  Sample 
contamination can be a problem, whether from keratin dust in the environment, from imperfect 
sample preparation, or incomplete purification, the detection limits of MS machines are so low 
that even miniscule amounts of contamination will likely be detected and reported [27].  Further 
complicating matters, MS may not be able to detect highly hydrophobic proteins which might 
precipitate out during the process, or proteins which lack trypsin cleavage sites, or which are 
simply not abundant in the sample [28].  The large data sets it is possible to produce with the use 
of Mass Spectrometry are both a blessing and a curse.  At present MS is unable to tell us what 
role (if any) identified proteins might be playing or whether that role is crucial or redundant.  
143
There are currently tools being produced to help with this including such things as pathway 
analysis software and interactome libraries which show great promise, but are still ultimately 
dependent upon experimental methods to fill out their data sets and increase the predictive power 
of these computer programs.  For the time being, there is still a need for proteins identified by 
MS to be validated by traditional biochemical and molecular biology techniques. 
In this dissertation we have used MS to generate both a large, potentially less accurate list of 
2,032 proteins that might be involved in the membrane raft microdomain in αT3-1 cells, and a 
shorter list of 129 proteins that immunoprecipitated along with both the GnRHR and flotillin out 
of membrane raft fractions.  We further went on to use complimentary techniques to validate that 
a selection of the proteins we identified here represent true participants within the GnRHR-
associated membrane raft proteome and potentially within the GnRHR-induced transcriptional 
network.  Many proteins still remain to be validated from these MS experiments and future 
studies will be needed to determine whether all of the proteins we identified hold biological 
relevance within the context of GnRHR signaling in pituitary gonadotropes.  It is also important 
to note that all of our MS studies were performed from cells at rest.  As we expect both 
membrane microdomains and cellular signaling processes to be highly dynamic, these studies 
might have missed several components of the signaling network which are recruited into the 
membrane raft compartment only following stimulation.  Future studies comparing cells at rest to 
cells stimulated for various lengths of time will be needed to fully characterize the GnRHR-
associated signaling network within the membrane raft compartment. 
GnRHR SIGNALING AND β CATENIN IN GONADOTROPE CELLS 
Pathway analysis of the 129 proteins identified by MS as noted above provides evidence that a 
number of these peptides are linked to known signaling pathways and cellular processes.  Unique 
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among the peptides identified by MS within the membrane raft compartment was β catenin. β 
catenin is a protein known for its ability to bind E-cadherin and as a signaling molecule in the 
Wnt/Frizzled signaling pathway.  In canonical Wnt signaling, β catenin translocates to the 
nucleus where it acts as a transcriptional coactivator on Wnt-responsive genes [29].  Recently, β 
catenin has been shown to participate in transcriptional coactivation of gonadotropin subunit 
genes in pituitary-derived LβT2 cells in response to GnRH stimulation [30].  Thus, β catenin 
may be playing a key role in pituitary gonadotrope function.   
 
In this dissertation we provide evidence that β catenin is present constitutively but not 
exclusively in membrane rafts from IP studies linked to the GnRHR and flotillin 1.  In αT3-1 
cells, GnRH administration resulted in a rapid translocation of β catenin to the nuclear 
compartment putatively independent of phosphorylation of GSK3β, a known modulator of β 
catenin activity.  We therefore hypothesized that β catenin likely regulates key gene 
transcriptional events linked to GnRH stimulation of gonadotropes.  Indeed overexpression of β 
catenin in αT3-1 cells induced activation of the promoter for Nur77; an orphan nuclear receptor 
known to be regulated by GnRH as an immediate early gene in gonadotropes.   Further this 
activation proved to be sequence- and promoter-specific.  The combined actions of β catenin and 
GnRH resulted in a synergistic activation of the Nur77 promoter suggesting important 
combinatorial action of GnRH signaling with β catenin.  These studies support the conclusion 
that membrane raft-localized β catenin may play a critical role in the expression of immediate 
early gene transcription induced by GnRH in gonadotropes.  
Missing from our current understanding is how GnRH stimulation is capable of activating β 
catenin.  Future studies to determine whether β catenin is phosphorylated in response to GnRH 
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treatment in αT3-1 cells will help to elucidate the mechanism by which raft-associated β catenin 
becomes activated and translocates to the nucleus.  As we have seen that overexpression of β 
catenin is sufficient to drive expression of a GnRH-inducible gene the obvious counterpart would 
be to determine whether β catenin is required for the activation of Nur77 transcription.  
Experiments utilizing siRNA knock down of β catenin followed by luciferase assays to 
determine whether basal or GnRH-induced activity of the Nur77 promoter is disrupted following 
loss of β catenin will be vital to understanding the role of β catenin in this system.  Similarly 
future studies to specifically identify and mutate the binding sites for β catenin on the Nur77 
promoter will help us to define how β catenin is capable of transactivating this promoter. 
Our studies also revealed an apparently synergistic response to overexpression of β catenin and 
GnRH stimulation on the activity of the Nur77 promoter.  This result points to the potential 
involvement of other transcription factors activated by GnRH treatment in modulating the 
activity of β catenin on the Nur77 promoter.  Several GnRH-responsive transcription factors are 
known including cJun and Fos.  Future experiments to overexpress or pharmacologically block 
activation of these transcription factors will help to determine the extent of their involvement in 
β catenin-associated activation of the Nur77 promoter.  Complementary studies including 
chromatin immunoprecipitation (ChIP) or mobility shift assays can also be utilized to determine 
what other factors may be involved in β catenin’s ability to recognize and activate specific 
promoter elements. 
SUMMARY 
The GnRHR-associated signaling network in pituitary gonadotropes is an amazingly complex 
system which is tightly regulated at all levels.  Despite decades of study there is much we still do 
not know about how the GnRHR is capable of coupling to downstream signaling targets 
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including ERK.  In this dissertation we provide evidence for the association of the GnRHR with 
flotillins and β catenin in membrane raft microdomains in gonadotrope cells.  We have further 
generated a list of proteins by Mass Spectroscopy that may be involved in mediating the 
GnRHR’s ability to stimulate actin cytoskeletal reorganization and induce downstream signaling 
events.  Future studies will be needed to better define which proteins from this list are involved 
in the GnRHR-associated signaling network and to characterize the requirement for these 
proteins in the coordination and control of fertility in animals. 
 
REFERENCES 
[1] Bedecarrats, G. Y. & Kaiser, U. B. Differential Regulation of Gonadotropin Subunit 
Gene Promoter Activity by Pulsatile Gonadotropin-Releasing Hormone (GnRH) in Perifused L β 
T2 Cells: Role of GnRH Receptor Concentration. Endocrinology 144, 1802–1811 (2003).  
[2] Kaiser, U. Molecular mechanisms of the regulation of gonadotropin gene expression by 
gonadotropin-releasing hormone. Molecules and Cells 8, 647–56 (1998). 
[3] Burger, L. L., Haisenleder, D. J., Dalkin, A. C. & Marshall, J. C. Regulation of 
gonadotropin subunit gene transcription. Journal of Molecular Endocrinology 33, 559–584 
(2004).  
[4] Pieper, D. R., Gala, R. R., Schiff, M. A., Regiani, S. R. & Marshall, J. C. Pituitary 
Gonadotropin-Releasing Hormone (GnRH) Receptor Responses to GnRH in Hypothalamus-
Lesioned Rats: Inhibition of Responses by Hyperprolactinemia and Evidence that Testosterone 
and Estradiol Modulate Gonadotropin Secretion at Postreceptor Sites. Endocrinology 115, 1190–
1196 (1984).  
147
[5] Clayton, R. N. & Catt, K. J. Gonadotropin-Releasing Hormone Receptors: 
Characterization, Physiological Regulation, and Relationship to Reproductive Function. 
Endocrine Reviews 2, 186–209 (Spring 1981).  
[6] Counis, R., Laverriere, J.-N., Garrel, G., Bleux, C., Cohen-Tannoudji, J., Lerrant, Y., 
Kottler, M.-L. & Magre, S. Gonadotropin-releasing hormone and the control of gonadotrope 
function. Reprod. Nutr. Dev. 45, 243–254 (2005).  
[7] Burger, L. L., Dalkin, A. C., Aylor, K. W., Haisenleder, D. J. & Marshall, J. C. GnRH 
Pulse Frequency Modulation of Gonadotropin Subunit Gene Transcription in Normal 
Gonadotropes - Assessment by Primary Transcript Assay Provides Evidence for Roles of GnRH 
and Follistatin. Endocrinology 143, 3243–3249 (2002).  
[8] Kaiser, U. B., Conn, P. M. & Chin, W. W. Studies of Gonadotropin-Releasing Hormone 
(GnRH) Action Using GnRH Receptor-Expressing Pituitary Cell Lines. Endocrine Reviews 18, 
46–70 (1997).  
[9] Ellsworth, B. S., White, B. R., Burns, A. T., Cherrington, B. D., Otis, A. M. & Clay, C. 
M.  c-Jun N-Terminal Kinase Activation of Activator Protein-1 Underlies Homologous 
Regulation of the Gonadotropin-Releasing Hormone Receptor Gene in αT3-1 Cells. 
Endocrinology 144, 839–849 (2003).  
[10] White, B. R., Duval, D. L., Mulvaney, J. M., Roberson, M. S. & Clay, C. M. 
Homologous Regulation of the Gonadotropin-Releasing Hormone Receptor Gene Is Partially 
Mediated by Protein Kinase C Activation of an Activator Protein-1 Element. Molecular 
Endocrinology 13, 566–577 (1999).  
148
[11] Cherrington, B. D., Farmerie, T. A., Lents, C. A., Cantlon, J. D., Roberson, M. S. & Clay, 
C. M. Activin Responsiveness of the Murine Gonadotropin-Releasing Hormone Receptor Gene 
Is Mediated by a Composite Enhancer Containing Spatially Distinct Regulatory Elements. 
Molecular Endocrinology 19, 898–912 (2005).  
[12] Navratil, A. M., Bliss, S. P., Berghorn, K. A., Haughian, J. M., Farmerie, T. A., Graham, 
J. K., Clay, C. M. & Roberson, M. S. Constitutive Localization of the Gonadotropin-releasing 
Hormone (GnRH) Receptor to Low Density Membrane Microdomains Is Necessary for GnRH 
Signaling to ERK. Journal of Biological Chemistry 278, 31593–31602 (2003).  
[13] Bliss, S. P., Navratil, A. M., Breed, M., Skinner, D. C., Clay, C. M. & Roberson, M. S. 
Signaling Complexes Associated with the Type I Gonadotropin-Releasing Hormone (GnRH) 
Receptor: Colocalization of Extracellularly Regulated Kinase 2 and GnRH Receptor within 
Membrane Rafts. Molecular Endocrinology 21, 538–549 (2007).  
[14] Bliss, S. P., Navratil, A. M., Xie, J. & Roberson, M. S. GnRH signaling, the gonadotrope 
and endocrine control of fertility. Frontiers in Neuroendocrinology 31, 322 – 340 (2010).  
[15] Simons, K. & Ikonen, E. Functional rafts in cell membranes. Nature 387, 569–72 (1997).  
[16] Bliss, S. P., Miller, A., Navratil, A. M., Xie, J., McDonough, S. P., Fisher, P. J., 
Landreth, G. E. & Roberson, M. S. ERK Signaling in the Pituitary Is Required for Female But 
Not Male Fertility. Molecular Endocrinology 23, 1092–1101 (2009).  
[17] Galbiati, F., Volonte, D., Goltz, J. S., Steele, Z., Sen, J., Jurcsak, J., Stein, D., Stevens, L. 
& Lisanti, M. P.  Identification, sequence and developmental expression of invertebrate flotillins 
from Drosophila melanogaster. Gene 210, 229 – 237 (1998).  
149
[18] Bickel, P. E., Scherer, P. E., Schnitzer, J. E., Oh, P., Lisanti, M. P. & Lodish, H. F. 
Flotillin and Epidermal Surface Antigen Define a New Family of Caveolae-associated Integral 
Membrane Proteins. Journal of Biological Chemistry 272, 13793–13802 (1997).  
[19] Solis G. P., Hoegg, M., Munderloh, C., Schrock, Y., Malaga-Trillo, E., Rivera-Milla, E., 
Stuermer, C. A. & Hoegg, M. Reggie/flotillin proteins are organized into stable tetramers in 
membrane microdomains. Biochemical Journal 403, 313–322 (2007).  
[20] Lang, D. M.,  Lommel, S., Jung, M., Ankerhold, R., Petrausch, B., Laessing, U., 
Wiechers, M. F., Plattner, H. & Stuermer, C. A. O. Identification of Reggie-1 and Reggie-2 as 
plasmamembrane-associated proteins which cocluster with activated GPI-anchored cell adhesion 
molecules in non-caveolar micropatches in neurons. Journal of Neurobiology 37, 502–523 
(1998).  
[21] Stuermer, C. A. O., Lang, D. M., Kirsch, F., Wiechers, M., Deininger, S-O. & Plattner, 
H. Glycosylphosphatidyl Inositol-anchored Proteins and fyn Kinase Assemble in Noncaveolar 
Plasma Membrane Microdomains Defined by Reggie-1 and -2. Molecular Biology of the Cell 12, 
3031–3045 (2001).  
[22] Rajendran, L., Masilamani, M., Solomon, S., Tikkanen, R., Stuermer, C. A. O., Plattner, 
H., Illges, H. Asymmetric localization of flotillins/reggies in preassembled platforms confers 
inherent polarity to hematopoietic cells. Proceedings of the National Academy of Sciences 100, 
8241–8246 (2003).  
[23] Babuke, T. & Tikkanen, R. Dissecting the molecular function of reggie/flotillin proteins. 
European Journal of Cell Biology 86, 525 – 532 (2007).  
150
[24] Sugawara, Y., Nishii, H.,Takahashi, T., Yamauchi, J., Mizuno, N., Tago, K. & Itoh, H. 
The lipid raft proteins flotillins/reggies interact with Gα q and are involved in Gq-mediated p38 
mitogen-activated protein kinase activation through tyrosine kinase. Cellular Signalling 19, 1301 
– 1308 (2007).  
[25] Pike, L. J. & Miller, J. M. Cholesterol Depletion Delocalizes Phosphatidylinositol 
Bisphosphate and Inhibits Hormone-stimulated Phosphatidylinositol Turnover. Journal of 
Biological Chemistry 273, 22298–22304 (1998).  
[26] Navratil, A., Knoll, J. G., Whitesell, J. D., Tobet, S. A. & Clay, C. M. Neuroendocrine 
Plasticity in the Anterior Pituitary: Gonadotropin-Releasing Hormone-Mediated Movement in 
Vitro and in Vivo. Endocrinology 148, 1736–1744 (2007). 
[27] Gauthier, D. J. & Lazure, C. Complementary methods to assist subcellular fractionation 
in organellar proteomics. Expert Review of Proteomics 5, 603–617 (2008). 
[28] Helbig, A. O., Heck, A. J. & Slijper, M. Exploring the membrane proteome-Challenges 
and analytical strategies. Journal of Proteomics 73, 868 – 878 (2010).  
[29] Cadigan, K. M. Chapter one - TCFs and Wnt/β-catenin Signaling: More than One Way to 
Throw the Switch. In Plaza, S. & Payre, F. (eds.) Transcriptional Switches During Development, 
vol. 98 of Current Topics in Developmental Biology, 1 – 34 (Academic Press, 2012).  
[30] Salisbury, T. B., Binder, A. K., Grammer, J. C. & Nilson, J. H. Maximal Activity of the 
Luteinizing Hormone β-Subunit Gene Requires β-Catenin. Molecular Endocrinology 21, 963–
971 (2007).  
 
151
